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ABSTRACT 
 
In the thesis, the preparation and characterization of polylactide-
Hydroxyapatite(HA) composite films for biomaterial applications have been studied. 
The effects of number of parameters such as polymer type, HA loading, surface 
modification and its concentration on the mechanical, thermal microstructural and 
hydrolytic degradation properties of the composites were investigated. Four different 
types of polymers, Poly (L-lactide)(PLA1), 96/4 L-lactide,D-Lactide Copolymer 
(PDLA1), Poly (L-Lactide)(PLA2), and 67/23 Poly (L-Lactide-co-D,L-
Lactide)(PDLA2), have been used. In this study, PolyLactide-HA composite films have 
been prepared by solvent-casting technique.  
The HA powder was synthesized by precipitation technique. Interfacial 
interactions between HA and polylactide polymer were modified to improve filler 
compatibility and mechanical properties of the composites by surface treatment of the 
HA with two different silane coupling agents; 3-aminopropyltriethoxysilane (AMPTES) 
and 3-mercaptopropyltrimethoxysilane (MPTMS) at three different concentration. 
Silane treatment indicated better dispersion of HA particles in the polymer 
matrix and improvements in the mechanical properties of the composites compared to 
the untreated HA loaded polylactide composites. Tensile test results showed that the 
maximum improvement in the mechanical properties of the composites was obtained for 
the PLA composites containing 1 wt % aminofunctional silane treated HA and 0.5 wt % 
mercaptopropyltrimethoxy silane treated HA for PDLA composites. Scanning electron 
microscopy studies also revealed better dispersion of silane treated HA particles in the 
polymer matrix. Thermal degradation kinetics of the composites was investigated and it 
was found that addition of HA into polymer matrix decreased the thermal degradation 
temperature and also slowed down the degradation rate. 
In this study, the hydrolytic degradation of poly (L-Lactide)(PLA), poly (L-
Lactide-co-D-Lactide) (PDLA) and their hydroxyapatite (HA) loaded composites (10-
50-w/w %) were investigated in simulated body fluid (SBF) at 37 0C and at pH 7.4 by in 
vitro static testing. Using different techniques, namely weighting to quantify water 
absorption monitored the hydrolytic degradation and weight loss, scanning electron 
microscopy (SEM) to observe morphological changes occurred at the surface of the 
films over time. At the end of the 150 days, only 12.5 wt % and 9.5 wt % of weight 
PLA1 and PLA2 were lost respectively. Degradation of the copolymers was faster than 
PLA1 and PLA2 and weight loss data of PDLA1 and PDLA2 were found to be nearly 
same with 17.5 wt % and 17 wt %, respectively. The changes of pH on all polymer were 
stable at 7.4, because of simulated body fluid indicates buffer solution properties. 
Degradation rate of PLA and PDLA composites containing 10 wt % HA decreased, and 
also water absorption of these samples increased. Weight loss decreased approximately 
from 12 wt % to 5 wt % and water absorption increased from 10 wt % to 13 wt % for 
PLA composites containing 10 wt % HA. The change of microstructural properties of 
obtained composites has been determined in simulated body fluid as a function of time. 
It was found that the surface of polymer composite films was coated with the calcium 
phosphate layer. This coating was increased with HA loading and ageing time. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ÖZ 
 
Bu çalışmada, polilaktid ve hidroksiapatit kompozit filmlerinin hazırlanması ve 
karakterizasyonu çalışılmıştır. Bir çok parametrenin; polimer tipi, hidroksisapatit yükü, 
yüzey modifikasyonu ve konsantrasyonun, mekanik, termal, mikroyapısal ve hidrolitik 
bozunma  özellikleri üzerine etkisi incelenmiştir. Dört farklı tip polimer, Polilaktid 
(PLA1), 96/4 L-Laktid,D-Laktid kopolimeri (PDLA1), Polilaktid (PLA2), ve 67 /23 Poli( 
L-Laktid- ko-D,L-Laktid ) kopolimeri (PDLA2) kullanılmıştır. Bu çalışmada, polilaktid 
ve hidroksiapatit kompozit filmleri çözücü yöntemi ile hazırlanmıştır. 
Hidroksiapatit (HA) tozları kimyasal çöktürme yöntemi ile sentezlenmiştir. 
Polilaktid-HA kompozitlerinin  mekanik özelliklerini ve dolgu maddesi ile polimer 
arasındaki yüzeyi geliştirmek amacıyla, HA tozlarının yüzeyi iki farklı silan 
bağlayıcıyla, üç farklı oranda ; 3-aminopropiltrietoksisilan (AMPTES) ve metioksisilan 
(MPTES) kaplanmıştır. 
Silan bağlayıcıları ile modifiye edilmiş HA tozları ile yapılan polilaktid 
kompozitlerinde işlem görmemiş HA tozları ile yapılan kompozitlere göre, HA 
tozlarının polimer matriksdeki dağılımı ve mekanik özelliklerinde gelişme gözlenmiştir. 
Çekme testi sonuçlarında, mekanik özelliklerindeki maksimum iyileşme, PLA 
kompozitleri için, kütlece % 1 oranında AMPTES silan ve PDLA kompozitleri için ise 
kütlece 0.5 % oranında MPTES silan ile kaplanmış HA tozlarında, elde edilmiştir. 
Taramalı elektron mikroskopu ile yapılan çaılşmalar silan ile modifiye edilmiş HA 
tozlarının polimer matriks içinde daha iyi dağıldığını göstermiştir. Kompozitlerin termal 
bozunma kinetiği incelenmiştir ve polimer matrikse HA ilavesinin hem termal bozunma 
sıcaklığını düşürdüğü hem de bozunma hızını yavaşlattığı bulunmuştur. 
Bu çalışmada, Polilaktid (PLA1), 96/4 L-Laktid,D-Laktid kopolimeri (PDLA1) 
ve onların HA kompozitlerinin (kütlece %10-50 HA yükü içeren) hidrolitik bozunma 
özelliği yapay vücut sıvısı ortamında 37 0C de 7.4 pH da statik test yöntemi ile 
araştırılmıştır. Zaman içerisinde, kompozitlerin su tutma kapasitesi, ağırlık kaybı ve 
kompozit yüzeyindeki morfolojik değişimlerin gözlenebilmesi için taramalı elektron 
mikroskopunun kullanılması gibi farklı teknikler kullanılarak hidrolitik bozunma 
özelliği gözlenmiştir. 150 günün sonunda, saf PLA1 ve PLA2 filmlerinde sırasıyla 
kütlece % 12.5 ve 9.5 kütle kaybı kaydedilmiştir. Kopolimerlerin bozunma hızları 
homopolimerlerden daha hızlıdır. PDLA1 ve PDLA2 için kütle kaybı değerleri oldukça 
yakın değerlerde, sırasıyla kütlece % 17.5 ve 17 olarak bulunmuştur. Bu zaman içerinde 
tüm polimerlerin bulunduğu ortamın pH değeri stabilitesini yaklaşık olarak 7.4 de 
korumuştur. Bunun nedeni yapay vücut sıvısının tampon çözelti özelliği göstermesidir. 
Kütlece % 10 HA içeren PLA ve PDLA kompozitlerinde bozunma hızının yavaşladığı 
ve bu örneklerde su tutma kapasitesinin arttığı görülmüştür. Kütlece % 10 HA içeren 
PLA kompozitleri için kütle kaybı değeri %12 den % 5’e düşmüş ve su tutma kapasitesi 
ise %10 dan %13’e yükselmiştir. Bu kompozitlerin yapay vücut sıvısında zamanla 
mikro yapısal özelliklerindeki değişim incelenmiştir. Polimer kompozit filmlerin 
yüzeyinin kalsiyum fosfat ile kaplandığı bulunmuştur. Bu kaplama, HA yükü ve 
bozunma zamanın artmasını sağlamıştır. 
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CHAPTER 1 
 
 
INTRODUCTION 
 
Thousands of patients throughout the world have the quality of their lives improved 
with the aid of some kind of implanted device. Diseases and accidents do damage human 
bodies. The materials from which implanted devices are constructed include metals, 
polymers, ceramics and an array of composites. As we reached the end of twentieth 
century, the success of using these materials increased, because of both improved surgical 
skill and better understanding of how the body interacts with such devices. In general, 
materials of natural or man-made origin that are used supplement, or replacing living 
tissues of human body are defined as biomaterials, that have two basic criteria: 
biocompatibility and biofunctionality. Success interaction between biomaterial and host is 
achieved when both surface and structural compatibilities are met. The success of a 
biomaterial in the body also depend on many factors such as surgical technique, degree of 
trauma imposed during implantation, sterilisation methods, health condition and activities 
of patients.  
Biomedical research and industrial area have been widely developed in the world in 
last forty years. Figure 1.1 indicates overview of the world market of biomaterials / 
biodevices area in % [1]. 
Bone fractures and damages are serious health problems, which result in more than 
1.3 million surgical procedures each year in the United States [2]. In the field of 
orthopaedic surgery, bone substitutes are often required to replace damaged tissue due to 
disease, trauma or surgery. Current bone substitutes do not exhibit the physiological and 
mechanical characteristics of the true bone. The development of artificial bone would seem 
to solve these problems, although it may be cause other problems. Up to the present, 
various kinds of materials such as ceramics, metals, polymers and their composites have 
also been used as artificial bone to fill bone defects or replace bony structure. Metallic 
materials, which are inert, have been beneficial in orthopaedic surgery. For example, 
metals or metal alloys render them valuable as load bearing implants as well as internal 
fixation devices in large part for orthopaedic applications as well as dental implants. 316 L 
stainless steel, titanium alloys, and cobalt alloys when processed suitably contribute high 
tensile, fatigue and yield strengths; low reactivate and good ductility to the stems of hip 
implant devices. One complication that can occur from the use of metals in orthopaedic 
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applications is the phenomenon of stress shielding. Lack of stress causes bone density to 
decrease as bone tissue resorbs, eventually baring the location and causing complications 
in the implant/tissue interface. This is known as the “use it or lose it” phenomenon and it 
applies to more than just bone tissue, including the brain. 
 
Figure 1. 1 Overview of the World Market of Biomaterials/ Biodevices Area in % 
 
Since the discovery that the bone tissue of mammals contains 69% calcium 
hydroxyapatite and remaining part is collagen protein, which are composite, great 
efforts have been made to develop phosphate ceramics as a potential implant material. 
Besides being biocompatible and non-toxic, this material exhibits unique 
osteoconductive properties. However, up to now, hydroxyapatite did not have 
mechanical properties necessary for this type of application. Low toughness of HA 
limited the application of this material as implants. Similarly, polymeric materials are 
used in biomedical applications, but mechanical and physical properties of polymers are 
not sufficient as an implant material and can cause some problems. One of the solutions 
of the problems is the development of the biocomposite. Nowadays, the developing of 
mechanical properties of the polymer/ceramic composite as the biomaterials have been 
investigated. Recently polymer/ceramic composite with polylactide (PLA) as the 
polymer phase has attracted great attention due to favourable characteristics of 
polylactide. PLA is a biodegradable polymer. These types of composites are partially 
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resorbable. The combination of a bioactive ceramics (HA) and bioresorbable polymer 
(PLA) is expected to result in a promising composite because of its bone–bonding 
potentials and ability to resorb. The polymeric part is metabolized and ceramic part is 
assimilated in the body. This composite has possible prospects for application as 
implant material in restricted load areas [3-7]. 
Many researchers have examined the preparation and characterization of 
hydroxyapatite/PLA composites in the last two decades. 
Ignjatovic et al [8] have studied the synthesis and properties HA/Poly-L-Lactide 
composite biomaterials. This study described optimization of the procedure for the 
production of HA/PLA composites using solvent casting technique. Designing of the 
material was achieved by cold and hot pressing at pressure ranges of 49-490 MPa and 
temperature ranges of 20-184 0C. The material obtained at optimum process parameters, 
had a density of 99.6%, maximum porosity of 0.4%, maximum compressive strength of 
93.2 MPa and Elastic modulus of 2.43 GPa was obtained. 
Kasuga et al [9] have examined preparation and mechanical properties of 
polylactic acid composites containing hydroxyapatite fiber. Solvent casting technique 
was used for preparation of the composites that were designed by hot pressing. HA fiber 
was found to be successfully integrated into the PLA matrix phase. The modulus of 
elasticity of the composite increased with increasing fiber content. The modulus of 
elasticity values has been obtained in the range of 5- 10 GPa for the 20-60-wt  % fiber 
loaded composites.  
Verheyen et al. [6,10] studied also physico-chemical properties of HA/PLA 
composites that were prepared by mixing HA particles with prior to L-Lactide  
polymerization. Three different buffer solutions were used; 0.1 M citric acid buffer 0.2 
M Gomori’s buffer and 0.2 M phosphate buffer saline. HA/ PLA composites with 30 or 
50 wt % HA showed linear release of calcium and phosphate ions and L-Lactide when 
incubated into different buffers within the tested incubation period of 24 weeks at pH of 
7.2. The composites were used as drug carriers because of the linear releases of the 
tested constituents. 
Higashi et al. [11] have combined poly(DL-Lactide) with HA in a 1:1 ratio to 
develop biodegradable artificial bone fillers where high mechanical strength is not 
required composites in vivo and in vitro. Composites were prepared by mixing before 
L-Lactide polymerization. Degradation studies were done in a distilled water medium at 
37 0C and pH 6.8. Specimens were analysed according to pH level, calcium 
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concentration and phosphorous concentration. The addition of hydroxyapatite showed a 
very slight increase in pH level with time. On the other hand, HA/PLA composite 
became acidic, pH level reached to 3.4 in a 1 week. 
Bleach et al [12] studied effect of filler content on mechanical properties of 
biphasic calcium phosphate (BCP) and polylactide composite films that were produced 
by solvent casting technique. The mixtures were stirred for at least 24h before casting 
onto clean glass slides. Homogeneous distribution of BCP particles in the films were 
observed but some agglomeration and void formation was seen in the composites 
containing larger volume fractions of BCP. In the composite all elongation arises from 
the polymer since the BCP is rigid relative to the PLA. 
In spite of the promising results obtained so far in PolyLactide-HA composite 
system, nobody has studied on the improvement of the interfacial interaction and 
adhesion between polymer and filler. The interaction and adhesion between ceramic 
filler and polymer matrix have a significant effect on the properties of the particulate 
filled reinforced materials, being essential to transfer the load between two phases and 
thus improve the mechanical properties. To improve the mechanical properties, it is 
necessary to render the surface of the filler and the polymer compatible, which can be 
achieved using several types of surface coupling agents. [13] Various methods have 
already been developed to improve the interfacial interactions between HA and a 
particular polymeric matrix: silane coupling agents [13,14,15], organic isocynates [14] 
and polyacids [15] are good examples. 
The objective of this study is to prepare and characterize PolyLactide-HA 
biocomposites for biomedical applications. The effects of number of parameters such as 
polymer types, HA loading, surface modification of HA and its concentration on the 
mechanical, thermal, microstructural and biodegradation properties of the biopolymer-
bioceramic composites have been studied. 
In this thesis, preparation and characterization biopolymer hydroxyapatite 
composites for biomaterials are outlined. Chapter 2 presents general information on 
biomedical materials, related terms, bone properties and structure. In chapter 3, the 
literature review of the polylactide and hydroxyapatite composites is given. Chapter 4 
deals with degradation mechanism of polylactide, its copolymer and Polylactide-HA 
composites. In chapter 5 and 6, the experimental study and the results and discussions 
are given. Finally, Chapter 7 presents the conclusion of this study with 
recommendations for future studies.   
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Chapter 2 
 
 
BIOMEDICAL MATERIALS, PRODUCTION AND THEIR 
APPLICATION 
 
2.1 Biomaterials and Their Developments 
 
Biomaterials are the materials of natural or man-made origin that are used to 
direct, supplement, or replace the functions of living tissues of human body are defined 
as biomaterials [4]. At the European Society of Biomaterials Consensus was agreed a 
new simple definition: “Biomaterial-a non-viable material used in a medical device 
intended to interact with biological system “ A synonymous term is “biomedical 
materials” [16].  
Biomaterials in the form of implants; such as sutures, bone plates, joint 
replacements, ligaments, vascular grafts, heart values, intraocular lenses, dental 
implants and medical devices, such as pacemakers, biosensors, artificial hearts, blood 
tubes are widely used to replace and/or restore the functions of traumatised or 
degenerated tissues or organs, to assist in healing, to improve function, to correct 
abnormalities and thus improve the quality of life of the patients. The use of certain 
materials as constituent of surgical implants is not new. Artificial eyes ears and noses 
were found on Egyptian mummy [3]. 
For centuries, when tissues became diseased or damaged a physician had little 
recourse but to remove the offending part, with obvious limitations. The discovery of 
antiseptics, penicillin and other antibiotics, chemical treatment of water supplies, 
improved hygiene, and vaccination all contributed to a major increase in human 
survivability in developed countries.  The revolution in medical care began with the 
successful replacement of tissue [4]. 
In the early days all kinds of natural materials such as wood, glue and rubber and 
manufactured materials such as gold, iron, zinc and glass were used as implants based 
on trial and error. Some materials were tolerated by the body whereas others were not. 
Unfortunately, a science in which materials other than these were considered as 
substances suitable for implantation was not developed until the mid-nineteenth century. 
Over the last 30 years considerable progress has been made in understanding the 
interactions between the tissues and the materials. For the next millennium, a working 
hypothesis should be Long-term survivability of prosthesis will be increased by the use 
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of biomaterials that enhance the regeneration of natural tissues. Historical development 
of biomaterials is indicated in Figure 2.1 [4]. 
 
Figure 2.1. Biomaterials Historical Development and Forecast for the Future [4]. 
 
2.2 Biocompatibility and Biofunctionality 
 
Two basic criteria; biocompatibility and biofunctionality control the 
performance of the biomedical material. Biomaterials must fulfil these criteria. 
Biofunctionality may be considered in relation to a set of properties, which allow a 
device to perform a function effectively and as long as necessary in or on the body 
while biocompatibility refers to the ability of device to continue to perform function 
[17]. 
Biocompatibility means that the material must not elicit an unresolved 
inflammatory response nor demonstrate extreme immunogenicity or cytotoxicity. In 
addition, because it degrades in vivo, this must be true not only for the intact material 
and any of its unreacted components, but also for the degradation products. The implant 
should be compatible with tissues in terms of chemical, surface and pharmacological 
properties. At the simplest level, it could be stated that biocompatibility means a total 
absence of interaction between material and tissue. 
The environment of the body is an aqueous medium, extremely well buffered so 
that pH is maintained at around 7.4 and it is held constant temperature 37 0C. The saline 
solution is an excellent electrolyte and facilitates electrochemical mechanism of 
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corrosion and hydrolysis. There are also many molecular and cellular species in the 
tissues, which have the ability to catalize certain chemical reactions or rapidly destroy 
certain components identified as foreign. Degradation of materials such as metals and 
polymers takes place in this aggressive environment. The response of the body is a 
complex issue, which could be dealt with in a number of ways. The important 
parameters that influence the response of the tissues include the type of tissue that is in 
contact with the material, the physical and chemical characteristics of the material and 
the general status of the host. There are different types of responses that are seen with 
varying distance from the surface [18]. 
In order to implant a material in the tissue, some surgical intervention is 
required. This surgical procedure will itself result in a wound healing processes. The 
tissue response to the material can therefore be seen as a modification of the wound 
healing process. The tissues will response to damage through a well-defined procedure 
involving two phases. The first phase, inflammation, is the initial reaction of the body to 
injury that involves localized change to microvasculature and the cellular composition 
of the tissue. The second phase is the repair phase in which the tissue attempts to restore 
the damage. The events that occur at the material-tissue interface could be controlled. 
The possibility of modifying such materials by using bioactive material interfacial 
reactions is especially significant and may be controlled. One of the best examples to 
this possibility is the use of HA and other calcium based materials to actively encourage 
bone regeneration at implant surfaces. Modification of polymer surfaces to improve 
their compatibility with blood is another significant example. 
Other characteristic of biomaterials is biofunctionality that is important in the 
function of an implant device made of biomaterials. Mechanical properties must be as 
similar as possible to those of the tissue that is to be regenerated. As well as providing 
proper support in the early stages of healing, graded load transfer is needed later in the 
process for creation of replacement tissue that is identical to the original. While many 
mechanical properties should be considered for materials to be used in orthopaedics, 
including those in compression, tension and torsion, compressive properties are the 
most relevant for replacement of cancellous bone, while tensile properties are important 
for cortical bone. The functional requirements of the materials include: 
Load transmission and stress distribution: The main point of the issue is the 
particular need for bone replacement or augmentation devices to be “iso-elastic” with 
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the adjacent bone. Cortical bone has a Young’s modulus in the region of 20 GPa as an 
example. This is not easily achieved in high strength materials. 
 Articulation: All joint replacements require low friction, low wear, and 
articulating surfaces to allow movement. 
 The control of blood and other fluid flow, simple space filling, generation and 
application of electrical stimuli, transmission of light and sound, the handling of drugs 
and other substances are some of the other important functional requirements. 
Besides these two terms, the bioinert, biointegration, biodegradation, 
bioresorption and bioactivity are important topics in biomaterials research. 
A non-viable materials used for medical purposes and interacting non-adversely 
with the living system. When no interaction occurs, the material is called “ bioinert”[4]. 
The integration of a biomaterial to bone involves essentially two processes; interlocking 
with bone tissue and chemical interactions with bone constituents. The direct bonding of 
orthopedic biomaterials with collagen is rarely considered, however several non-
collagenic proteins have been shown to adhere to biomaterial surface. Biodegradation, 
that is, gradual break down of a material mediated by specific biological and/or 
biochemical activity. Biodegradation is determined by physical-chemical factors and 
cell behaviour and is also affected by surgery. Bioresorption, that is, the removal 
process through cell activity (directly by phagocytosis or indirectly by enzymatic 
action) and/or through dissolution by continuous ionic diffusion of the material 
continuous ionic diffusion of constituting the device body, when placed in a biological 
environment. Bioactivity, that is, the behaviour of a material designed to induce a 
specific biological activity.  The biological activity of most orthopedic biomaterials is 
related to their ability to promote the formation of a formed layer of carbonate apatite 
crystals analogous to bone mineral, this layer also associates specific bone proteins and 
is the starting point of bone reconstruction [16]. 
 
2.3. Types of Biomaterials and Applications 
 
The various materials used in biomedical applications may be grouped into 
metals, ceramics, polymers, and composites and can be classified according to the 
material type or their applications. A classification based on type of biomaterials is 
given in Table 2.1 [19]. 
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Table 2.1 Biomedical materials and applications [19]. 
Material                Application 
 
Nondegradable Synthetics-Commodity Polymers 
Polymides                  Suture 
Polyesters                          Vascular Grafts 
Polyformaldehyde                    Heart Valve Stents 
Polyolefins                        Sutures, mesh for hernia repair 
Polyvinly  choloride                     Tubing, blood bags 
 
Nondegradable Synthetics- Value-Added Polymers 
Fluorocarbons                           Vascular grafts 
Hydrogels                      Contact lenses, catheter coatings 
Polyolefin elastomers                        Tubing, artificial heart bladder 
Polyurethanes                  Catheters, artificial hearts bladders 
Silicones                     Soft tissue reconstruction, tubing 
Ultrahigh molecular weight polyethylene                        Acetabular cup 
 
Biodegradables 
Albumin, cross-linked              Vascular graft coatings, Cell encapsulation  
Collagen/gelatin, cross-linked             Soft tissue reconstruction, Vascular graft coatings 
Polyamino acids                                                Controlled release, Cell adhesion peptide 
Polyanhydrides                      Controlled release 
Polycaprolactones                                              Controlled release, bone plates 
Polylactic/glycolic acid copolymers                Sutures, bone plates 
Polyhydroxybutyrates                       Controlled release, bone plates 
Polyorthoesters                       Controlled release, bone plates 
 
Biologically Derived Materials 
Bovine carotid artery                 Vasular grafts 
Bovine ligaments                        Ligaments 
Bovine pericardium                 Pericardial substitute, heart valves 
Human umbilical vein                         Vascular grafts 
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Porcine heart valve                    Heart valves 
 
Bioderived Macromolecules 
Chitosans                         Experimental, wound dressing, Controlled release 
Collagen                  Soft tissue injectables, coatings, Wound dressing 
Elastin                      Experimental, coatings 
Gelatin, cross-linked                                                Artificial heart bladder coating 
Hyaluronic acid                                      Coating, wound dressing, Surgical non-adhesion 
 
Tissue Adhesives 
Cyanoarcylates                          Wound closure, microsurgery 
Fibrin glue                            Vascular graft coating 
Molluscan glue                     Enhancement of cell adhesion, Vascular stents 
  
Metal and Metallic Alloy 
Cobalt chorome molybdenum alloys                                 Heart valve stents 
Nitrol alloys (shape memory alloys)                                 Orthopedic wire 
Stainless steels                                                                     Orthopedic wire 
Titanium and titanium  alloys                       Artificial heart housing,  Heart Valve Stents 
 
Ceramics, Inorganics and Glasses  
Aluminum, calcium, and phosphorous     Degradable  bone filler, enhanced bone growth 
Bioglass          Bioactive phosphorous calcium glass,orthopedic coating 
Glass Ceramic                Encapsulation of implantable, medical electronics 
High density alumina             Acetabular cup, ball of hip prosthesis  
Hydroxyapatites                 Bioactive ceramic, orthopedic coatic bone fillers 
Glassy Carbons                     Fiber for orthopedic composites 
Pyrollytic(low temperature isotropic)carbon            Heart valves, dental implants 
Ultra low temperature isotropic carbon            Coatings on heat sensitive polymers 
   
Passive Coatings 
Albumin                                            Thromboresistance 
Alkyl chains                      Adsorbs albumin for thromboresistance 
Fluorocarbons           Reduced drag for catheters, thromboresistance 
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Hydrogels                        Reduced drag for catheters, thromboresistance 
Silica-free silicone                                  Thromboresistance, improved wound healing 
for soft tissue reconstruction 
 
Bioactive Coatings 
Anticoagulants, e.g, heparin and hirudin                Thromboresistance 
Bioactive Ceramics and glasses Bone adhesion and formation; soft tissue adhesion 
Cell adhesion peptides              Enhanced cell adhesion, epithelium,      
Cell adhesion proteins              Enhanced cell adhesion, epithelium,  
Negative Surface Charge                                                               Thromboresistance 
Thrombolytics                                                                 Thromboresistance 
 
2.3.1. Metals and Alloys 
 
Metals and alloys are successful as biomaterials that have excellent mechanical 
durability. Metals are known for high strength, ductility and resistance to wear.  
Shortcomings of many metals include low biocompatibility, corrosion, too high 
stiffness compared to tissues, high density and release of metal ions that may cause 
allergical tissue reaction. 
Usage of metals as biomaterials include that [20].  
1. Stainless steel (nickel chrome molybdenum alloy, 316L): Type 316L stainless steels. 
It is the first material used to produce an artificial bone. It is cheaper and easily cast 
into different shapes, but is not necessarily durable. 
2. Cobalt chromium alloy: This alloy is less susceptible to corrosion, fatigue and wear 
the stainless steel, but heavy, any large prostheses need to be hallows. 
3. Titanium alloy (Ti-6Al-4 Va): Titanium alloys are lighter than others. For this 
reason, these alloys are used for prostheses to replace large joints such as the hip and 
the knee. In addition it has an excellent biocompatibility. This alloy is the most 
widely used one in the last two-decade. 
Use of metallic material is a common practice in traumatology and orthopedic 
surgery, leading to good clinical results by stable fixation of the bony fragments. But the 
deficiency of load transmission during the process of bone healing, due to the stress 
protection by the rigid metallic plates and some possible disadvantages of long lasting 
metallic fixation described above such as inflammative reactions of the surrounding 
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tissues or allergic reactions, caused by corrosion products and finally migration of 
screws, seen occasionally after surgery, require the surgical removal of metallic 
implants after fracture healing [21]. 
 
2.3.2. Ceramics 
 
Ceramic consists of inorganic, non-metallic compounds that exhibit a variety of 
combinations of ionic and covalent bonding, which are the oldest man-made materials. 
Since ancient times, ceramic materials have found extended application in products 
serving human hygiene such as sewage pipe systems and many kinds of sanitary ware 
[22]. 
During the last forty years a revolution has occurred in the use of ceramics to 
improve the quality of human life and in some cases the length of the life. This 
revolution is the development of specially designed and fabricated ceramics for the 
repair and reconstruction of diseased, damaged or worn out parts of the body. Ceramics 
used for this purpose are called as bioceramics. Bioceramics are generally used as 
implants usually hard tissue applications such as bones and tooth. They can be bioinert 
(e. g. alumina), resorbable (e. g. tricalcium phosphate), bioactive (e. g. Hydroxyapatite, 
bioactive glass) or porous for tissue ingrowth (e. g. metals coated with HA). 
In restorative dentistry, the classical silicate ceramics have been widely used. 
Porcelains and multilayered enamels with colours and other carefully adjusted 
properties allow the reconstruction of tooth crowns, the bridging of gaps above missing 
teeth and for cosmetically acceptable partial and complete dentures. For implants, 
however, silicate containing classical ceramics can not be used because of their 
solubility in body fluids [22]. 
There are many types of bioceramics available at present for biomedical 
applications and they fall into two main categories: the alumina and calcium phosphate 
ceramics. 
Alumina (Al2O3) Ceramics: Alumina is extracted from bauxite by heating and 
hydrolysis. Precious stones such as rubies and sapphires are natural single crystals of 
alumina. However, the usage of alumina in artificial bones and joints and as filling for 
bony defects left after the excision of lesions. 
Calcium Phosphate Ceramics: Those mode of Ca10(PO4)6(OH)2 or 
hydroxyapatite (HA) are the most well-known type of ceramic in this group. The 
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structural formula of HA is the same of that for the inorganic component of bone, and 
synthetic HA can be regarded as equivalent to bone itself. Its affinity for bone is far 
higher than that alumina. Consequently, this material is ideal as filling for bony defects. 
However, low thougness of HA limited its application in high load bearing applications. 
In order to overcome the problem of brittleness of HA, a number of attempts have been 
made to increase durability HA ceramic materials.  
The use of bioceramics depends on achieving a stable attachment to the 
connective tissue and a match of mechanical behaviour of the implant with the tissue to 
be replaced. Survivability of a bioceramic requires the formation of a stable interface 
with living host tissue. The mechanism of tissue attachment is directly related to the 
type of tissue response at the implant interface. The four types of response as 
summarised in Table 2.2 allow different means of achieving attachment of prostheses to 
the musculo-skeletal system [23]. 
 
Table 2.2 Types of Implant–Tissue Response [23] 
If the materials toxic, the surrounding tissue dies. 
If the material is non-toxic and biologically inactive (almost inert), 
    A fibrous tissue of variable thickness forms. 
If the material is non-toxic and biologically active(bioactive), 
   An interfacial bond forms. 
If the material is non-toxic and dissolves, the surrounding tissue replaces it. 
 
Some mechanical properties of metallic and ceramic materials are summarised 
in Table 2.3. Much interest is still focused on those ceramics, which resemble more or 
less closely the mineral phase of bony tissue like hydroxyapatite. 
Although bioceramics are known for their good biocompatibility, corrosion 
resistance, drawbacks of ceramics include brittleness, low fracture strenght, difficult to 
fabricate, low mechanical reliability and high density. Polymer and its composites 
materials provide alternative choice to overcome many shortcomings of homogeneous 
materials mentioned above such as ceramics or metals. The advantages of the polymer 
and its composites are highlighted in the following sections.  
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Table 2.3 Some mechanical properties of metallic and ceramic material [3]. 
Material Modulus (GPa) Tensile Strength (MPa) 
Stainless Steel 190 586 
Co-Cr Alloy 210 1085 
Ti-Alloy 116 965 
Amalgam 30 58 
Alumina 380 300 
Zirconia 220 820 
Bioglass 35 42 
Hydroxyapatite 95 50 
 
2.3.3. Polymers 
 
Polymers have very long chain molecules, which are formed by covalent 
bonding along the backbone chain. The long chains are held together either by 
secondary bonding forces such as Van der walls and hydrogen bonds or primary 
covalent bonding forces through cross links between chains. Their structural and 
chemical features control properties of polymers. Foremost among these is the high 
molecular weight that arises from the repetitive linking of the repeating unit or units to 
form long-chains, the length of which has a profound effect on the properties of the 
polymer. The physical properties of polymers can be affected in many ways. In 
particular, the chemical composition and arrangement of chains will have a great effect 
on the final properties.  
Polymers have many advantages [24] 
 are available with a wide variety of mechanical and physical     properties 
 are relatively readily formed into the desired shape 
 are considered inert toward the host tissue 
 are available at reasonable cost  
Polymer scientists, working closely with those in the device and medical fields, 
have made enormous advances over the past 30 years in the use of synthetic materials in 
the body. Synthetic polymeric materials have been widely used in medical disposable 
supplies, prosthetic materials, dental materials, implant, dressings, extracorporeal 
devices, encapsulate, polymeric delivery system and orthopedic devices [24].  Although 
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hundreds of polymers are easily synthesised and could be used as biomaterials, only ten 
to twenty polymers are mainly used as medical device fabrications.  
There are two types of polymers according to degradation in the body. Non-
resorbable polymers such as polyethylene, polypropylene, polymethylmetacrylate have 
been widely used as biomedical application for a long time. Resorbable (or 
biodegradable) polymers such as polyglycolic acid, polylactic acid, polycarbonate, 
chitosan have been also used.  
The ideal polymer for an application would have the following properties: 
 Does not evoke an inflammatory/toxic response, disproportionate to its 
beneficial effect, 
 Is metabolized in the body after fulfilling its purpose leaving no trace, 
 Is easily processed into the final product form, 
 Has acceptable shelf life, is easily sterilized. 
The mechanical properties match the application so that sufficient strength 
remains until the surrounding tissue has healed. Table 2.4 gives some mechanical 
properties of polymeric biomaterials. As seen in the Table 2.4, the mechanical 
properties of the polymers are too weak to meet the mechanical property demands of 
certain applications e. g. as implants in orthopaedic surgery. Therefore the composite 
materials provide alternative choice to overcome the disadvantages of homogeneous 
materials. 
  
Table 2.4 Some mechanical properties of polymeric materials [3]. 
Material Modulus 
(GPa) 
Tensile Strength 
(MPa) 
Polyethylene (PE) 0.88 35 
Polyurathane (PU) 0.02 35 
Polytetrafluoroethylene 0.5 27.5 
Polyacetal (PA) 2.1 67 
Polymethylmethacrylate (PMMA) 2.55 59 
Polyethyleneterephtalate (PET) 2.85 61 
Polyetheretherketone 8.3 139 
Silicone rubber 0.008 7.6 
Polysulfone 2.65 75 
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2.2.4 Composites 
 
Composite materials are solids that contain two or more distinct constituent 
materials or phases, on a scale larger than the atomic. [24] There are three important 
points to be included in the definition of composite material:  
 It consists of two or more physically distinct and mechanically separable materials. 
 Mixing the separate materials in such a way can make that the dispersion of one 
material in the other can be done in a controlled way to achieve optimum properties. 
 The properties are superior, and possibly unique in some specific respects, to the 
properties of the individual components. 
The properties of composite materials depend very much on their structure. 
Composites differ from homogeneous materials in that considerable control can be 
exerted over the larger-scale structure and hence over the desired properties. In 
particular, the properties of a composite material depend on the shape of the 
inhomogeneities, the volume fraction occupied by them, and the interface among the 
constituents. 
The methods for producing a composite material by compounding different 
materials with each other can be classified according to the reinforcing systems by 
which the dispersive material (reinforcing material) is distributed in the matrix as 
follows [25]: 
(i) Dispersion-strengthened composite materials, 
(ii) Particle-reinforced composite materials, and 
(iii)  Fiber-reinforced composite materials.  
Figure 2.2 illustrates the classification of composite materials according to 
reinforcing system [25]. 
Figure 2.2. Comparison of Morphologies in Composite Materials [25] 
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Natural biological materials tend to be composites. Bone, dentin, cartilage, skin 
are natural composites which exhibit hierarchical structures in which particulate, porous 
and fibrous structural features are seen on different microscales. Composite materials 
offer a variety of advantages when compared to homogeneous materials. Composite 
systems can be divided into various classes based on the type of the components: 
Polymer/ceramic composite, ceramic/metal composites, ceramic/ceramic composite and 
so on.  
Ceramics have been used in biomedical material. Besides being biocompatible 
and non-toxic, this material exhibits unique osteoconductive properties. However, 
ceramics did not have mechanical properties necessary for some types of application. 
They are hard and brittle and not suitable for handling and processing into different 
forms as structural biomaterials. For example, low toughness of ceramics limited the 
application of this material as implants. Similarly, polymeric materials are used in 
biomedical applications, but they have some problems associated with mechanical and 
physical properties for load bearing applications. Recently, attention has been given to 
the applications of bioceramic in combination with biopolymers. The idea of using 
polymers to produce composites with improved handling and retention characteristics 
and to overcome the problem of brittleness associated with ceramic bone repair implants 
has been evaluated as an attractive approach. There are also other reasons of choosing 
polymer/ceramic composite biomaterials: 
 Absence of corrosion and fatigue failure of metal alloys and release of metal ions 
such as Ni or Cr which may cause loosening of the implant, patient discomfort and 
allergic skin reactions and low fracture toughness of ceramic materials which make 
them a difficult choice for load bearing applications. In addition, composite biomaterials 
have several other advantages. Metal alloys and ceramics are radio opaque and 
sometimes they undesirable artifacts in x-ray radiography. However, polymer composite 
materials can be made radio transparent. Polymer composite materials are fully 
compatible with modern diagnostic methods such as computed tomography (CT) and 
magnetic resonance imaging (MRI). 
Biopolymer/ bioceramic composites are widely used in biomedical application. 
Composite systems comprised of inorganic (bioceramic) fibers or particles, and organic 
polymers can be divided into three classes as follow [25]. 
 both non-bioresorbable reinforcing and matrix components such as CaO - P2 O5 
– SiO2 – Al2O3 (CPSA) glass fibers with polymethylmethacrylate (PMMA), 
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carbon fibers (CF) with epoxy resingraphite fibers with polyetheretherketone 
(PEEK) or polyester 
 bioactive particles for reinforcement with a non-bioresorbable polymer as matrix 
such as sintered hydroxyapatite (s-HA) particles with high density polyethylene 
(HDPE), bioglass particles with polysulphone (PS) 
 bioactive but not  totally resorbable reinforcing components with a bioresorbable 
matrix. Such as; Calcium metaphosphate (CMP) fibers with Poly D,L- Lactide, 
HA particles with polyhydroxybutylate (PHB), HA Particles with poly L 
Lactide. 
Polymer composite biomaterials are particularly attractive for their suitable 
manufacturing process and biological and mechanical properties comparable to those of 
the host tissues. Various applications of different polymer composite biomaterials are 
summarised in Figure 2.3 [3].  
 
Figure 2.3. Various Applications of Different Polymer Composites [3]. 
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Ramakrishna and co-workers [3] classify composite materials into subgroups 
as shown in figure 2.4. A composite material made of avital (non-living) matrix and 
reinforcement phases, is called ‘avital/avital composite’. Alternatively, a composite 
material comprising of vital (living) and avital materials is called ‘vital/avital 
composite’. The avital/avital composites are analogous to polymer composites known to 
engineers. The avital/ avital composites are further divided into non-resorbable, partially 
resorbable and fully resorbable composite biomaterials. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4. Classification of Man-made Polymer Composite Biomaterials. 
 
One of the most interesting approaches to improve the reliability and to decrease 
the stiffness of the HAp biomaterials is the fabrication of HAp/polymer composites. 
Bonfield and co-workers [26,27,28] have developed HAp/high density 
polyethylene (HDPE) composites since the early 1980s as an analogue for bone 
replacement. With increasing HAp content, both Young’s modulus and bioactivity of 
the composites increase, while ductility decreases. The HAp/polyethylene composites 
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exhibit brittle/ductile transition at a HAp volume content of 40-45%. Their Young’s 
modulus is in the range of 1-8 GPa, which is quite close to the Young’s modulus of 
bone. As compared to the cortical bone, the composites have superior fracture toughness 
for HAp concentrations lower than 40% and similar fracture toughness in the 45-50% 
range. Unfortunately, The HAp/polyethylene composites are not biodegradable. 
Moreover, the presence of bioinert polyethylene decreases the ability to bond to the 
bone. 
Other studies of polymer composites with ceramic fillers have also been 
investigated over last two decades. Mikos et al., reported the results of a poly(propylene 
fumarate) (PPF) biodegradable bone cement that can be combined with a leachable 
component and injected into osseous defects [29]. The injectable nature of the material 
allows it to fill irregular osseous defects, and the leachable component allows room for 
bone ingrowth. This particular material also has potential as a drug delivery system. 
Composite systems can be formed with tricalcium phosphate (TCP) to improve 
mechanical integrity [29]. Similarly, Bennett et al., showed that a poly-dioxanone-co-
glycolide based composite reinforced with HA or TCP can be used as an injectable or 
moldable putty [30]. Greish and co workers studied the effect of bioactive glass on the 
mechanical properties of Hydroxyapatite-Ca polyacrylate composites. They found that 
the mechanical properties of these composites were enhanced by the addition of 
bioactive glass [31].  
Jansen et al. [32] prepared a sheet of poly (ethyleneglycolterephtalate) / poly( 
butyleneterephthalate) coated with HA powder and found good properties for tissue 
regenaration membrane. However, these kinds of composite were not easily cast: for 
this reason, their applications were limited.  
Bleach et al [12] studied effect of filler content on mechanical properties of 
biphasic calcium phosphate (BCP) and polylactide composite films that were produced 
by solvent casting technique using chloroform as a solvent. The mixtures were stirred 
for at least 24h before casting onto clean glass slides. Homogeneous distribution of BCP 
particles in the films were observed but some agglomeration and void formation was 
seen in the composites containing larger volume fractions of BCP. In the composite all 
elongation arises from the polymer since the BCP is rigid relative to the PLA.  
Shikinami and co-workers [25] have examined ultra high strength resorbable 
implants that were made from bioactive ceramic particles/PLA composites. The small 
granules uniformly distributing HA microparticles within a PLA matrix which were 
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obtained by precipitating polymer solution, dropping ethanol into dichloromethane-
polymer solution, were extruded to make a thick billet. Thereafter, the billet was formed 
into a thin billet by compression molding at 103 0C. The composites were filled with 
20,30,40 and 50 weight fractions of HA particles. Effects of u-HA contents on the 
mechanical properties of u-HA / PLA were investigated in their study. The gradual 
decrease in tensile strength was inversely proportional to the fraction of HA particles, 
but a high enough strength of over 100 MPa was maintained and this was sufficient for 
practical use as bone fixation devices. The high mechanical strength, the high bending, 
shear, and impact strengths and the high bending modulus of these composites depend 
on the mechanical interlocking between the HA particles and PLA matrix.  
 
2.4. Structure and Properties of Bone 
 
There are many types of bone fractures depending on the crack size, orientation, 
morphology, and location. Bone fractures are treated anatomic reduction in different 
ways and they may be grouped in to two types namely external fixation and internal 
fixation. The external fixation does not require opening the fracture site whereas the 
internal fixation requires opening the fracture site. In the internal fixation approach the 
bone fragments are held together by different ways using implants such as wires, pins, 
screws, plates and intramedullary nails [3]. 
The physical, chemical and mechanical properties of bone are important 
parameters for successful production of artificial bone replacement implants and bone 
fixation devices. Hard tissue, are often used as synonyms for bone when describing the 
structure and properties of bone. 
 
2.4.1. Composition of Bone 
 
Bone is anisotropic, heterogeneous, inhomogeneous, nonlinear, 
thermorheologically complex, viscoelastic material. It’s function is “load carrying”.  
Bone is one of the most interesting materials known in terms of structure property 
relationship. 
Bone in human and other mammal bodies is generally classified into two types:  
1) Cortical bone, also known as compact bone  
2) Trabecular bone, also known as cancellous or spongy bone. 
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These two types are classified as on the basis of porosity and the unit 
microstructure. Cortical bone is much denser with porosity ranging between 5% and 
10%. Cortical bone primarly is found in the shaft of long bones and forms the outer 
shell around cancellous bone at the end of joints and the vertebrae. Figure 2.5 shows 
hierarchical level of structure in human femur [33]. 
 
 
Figure 2.5 Organisation of Typical Bone [33]. 
 
The composition of bone depends on a large number of factors, the species, which 
bone, the location from which the sample is taken, and the age, sex, and type of bone 
tissue, e.g., cancellous, cortical. But a rough estimate for overall composition by volume 
is two-third hydroxyapatite, nearly one-third collagen and other organic components, 
and water. It is indicated that bone is a composite material. Some data in the literature 
for the composition of adult human bone is given in Table 2.5. 
 
Table 2.5 Composition of the human bone [33]. 
Components Amount( wt%) 
Mineral (apatite) 69% 
Organic Matrix 
Collagen 
Others 
22% 
90-96% of organic matrix 
4-10% of organic matrix 
Water 9% 
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The process of bone mineralization is complex and for the most part still 
unknown. The large quantities of cations and complex anion groups that are found 
under chemical analysis of bone, are Ca+2, PO4-3, CO3-2. Other ions are present in 
smaller quantities such as: Mg+2, Fe2+, F-, Cl- and also present are very small amounts of 
Na+ and K+ ascorbic acid, citric acid, polysaccharides in the two-third inorganic part. 
Calcium and phosphate ions lead to formation of salts, primarily 
calciumtriphosphate and hydroxyapatite, is in a crystalline form, which constitutes the 
framework providing the principal mechanical characteristics of bone. The apatite 
crystals are formed as needles, 20-40 nm in length by 1.5-3 nm in thickness, in the 
collagen matrix. The mineral phase present in the bone is not a completely discrete 
aggregation of calcium phosphate mineral crystals. It is made up of a continous phase.  
Organic part of the bone contains 90-95 % of collagen protein fibres that is 
chemically characterised by a high content of aromatic amino acid. Collagen fibres are 
surrounded in bone by a supporting substance referred to as ‘cement’. This organic 
cement, along which bone mineralises, fills the spaces between fibrils [7]. 
 
2.4.2. Mechanical Properties of Bone 
 
It is important to examine some characteristic properties of bone not normally 
taken into consideration. The mechanical properties of bone depend on the humidity, 
rate of loading and direction of the applied load. During daily activities bones are 
subjected to a stress of approximation 4 MPa. The mean load on a hip joint is up to 3 
times body weight and peak loading during jumping can be as high as 10 times body 
weight. More importantly, these stresses are repetitive and fluctuating depending on the 
activities such as standing, sitting, jogging, and climbing. The effect of rate of loading 
on the bone is shown in Figure 2.6 [33]. 
Organic components of bone (mainly collagen) themselves would behave as a 
compliant material with high thougness, low modulus, and other property characteristic 
for polymers. Inorganic components, i.e., HA crystals, provide appropriate stiffness to 
the bone. As a ceramic-organic composite, bone exhibits high toughness and relatively 
high modulus. High toughness is related not only to the presence of collagen, but also to 
the complicated fibrous microstructure [23].  
Figure 2.6 represents a linear elastic region, followed by a flat plastic region at 
about 0.8% strain. Failure occurs at strains up to 3 %. It is necessary to mention that 
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bone is a tough material at low strain rates. The slope of the stress strain curve, i.e., the 
stiffness of the bone, increases with increasing mineral content. Bone exhibits excellent 
toughness (at low strain rates) mostly due to its hierarchical structure, which stops 
cracks after little propagation. The main toughening mechanisms seem to be 
microcracks, which appear in the plastic region of the stress-strain curve [23]. As can be 
seen in the Figure 2.6. The Young Modulus, ultimate compressive and yield strength 
increase with increased rate of loading. However, failure strain and fracture toughness 
of the bone reach a maximum and then decrease. This implies that there is a critical rate 
of loading. The mechanical properties of human compact bone are summarised in the 
Table 2.6 [7]. 
 
 
Figure 2.6 Stress as a Function of Strain and Strain Rate for Human Compact Bone. 
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Table 2.6 Mechanical Properties of a Compact Human Bone. 
Properties 
 
Test direction related to bone axis 
  Parallel                                    Normal 
Tensile  Strength  124-174 MPa                            49 MPa 
Compressive Strength 170-193 MPa                          133 MPa 
Bending Strength 160 MPa 
Shear Strength 54 MPa 
Young’s Modulus 17-18.9 GPa                           11.5 GPa 
Work of fracture 
 
6000 (low strain rate) 
98 (high strain rate) 
Ultimate Tensile Strain 0.014 - 0.031                           0.007 
Ultimate Compressive Strain 0.0185-0.026                           0.028 
Yield tensile strain 0.007                                        0.004 
Yield compressive strain 0.010                                        0.011 
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CHAPTER 3 
 
POLYLACTIDE HYDROXYAPATITE COMPOSITES 
 
Bioabsorbable devices which are new in biomedical applications for internal 
fixation of fractures, osteotomies, ligament and meniscal injuries, support the fixation, 
decompose gradually, and the stresses are transferred to the healing tissue during 
healing. Bioabsorbable devices do not require a removal operation so that decreasing 
the total cost of treatment when compared to inert material. These devices have been 
clinical use only for 15 year. Applications of bioabsorbable devices will continue to 
increase in orthopedic surgery. These materials will have a more significant part in 
modern surgical technique. 
Ceramic/polymer composites have some advantages over pure ceramics and 
polymers. Recently ceramic/polymer composite with polylactide(PLA) as the polymer 
phase has attracted great attention due to favourable characteristics of polylactide. PLA 
is a biodegradable polymer. These types of composites are partially resorbable. The 
combination of a bioactive ceramics (HA) and bioresorbable polymer (PLA) is expected 
to result in a promising composite because of its bone –bonding potentials and ability to 
resorb. The polymeric part is metabolized and ceramic part is assimilated in the body. 
This composite has possible prospects for application as implant material in restricted 
load areas. In this study, Poly (L- Lactide) and Poly (L-Lactide-DL–Lactide) copolymer 
were used as the matrix material and hydroxyapatite was used as the filler. 
 
3.1.Hydroxyapatite 
 
  
Calcium Phosphate Ceramics (CPC) are ceramic materials with varying calcium 
to phosphate ratios. They have considerable potential as bone substitute materials. 
These ceramics have been used in medicine and dentistry for nearly 30 years. Different 
phases of CPC’s are used depending upon whether resorbable or bioactive material is 
desired. CPC’s with Ca/P ratio in the 1.5-1.67 range are the most interesting and useful 
materials. Ca/P ratio of Tricalcium phosphate (TCP) is 1.5. Ca/P ratio of Calcium 
hydroxyapatite (HA) is 1.67. These materials have been widely investigated [34]. 
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Hydroxyapatite is a major component of the inorganic compartment of the bone. 
Hydroxyapatite Ca10(PO4)6(OH)2  (Ca/P=1.67) and tricalcium phospahate Ca3(PO4)2  
(Ca/P= 1.5) are widely used in biomedical application for  load bearing implants and the 
dental industry due to excellent biocompatibility and bioactivity. Unfortunately, 
mechanical properties of pure HA ceramics are poor. Most members of this group are 
characterised by a high Young’s modulus, very low elasticity, and a hard, brittle surface 
[4]. 
Hydroxyapatite (HA), specifically, calcium hydroxyapatite, has a definite 
crystallographic structure, belongs to the hexagonal system. An ideal weight percentage 
of HA is 39.9 % Ca, 18.5 % P, 3.38 % OH. [18] Schematic crystal structure of HA is 
showed in Figure 3.1 [34]. The ideal Ca/P ratio of HA is 5:3 and the calculated density 
3.219 g/cm3. The differences in structure, chemistry and composition of apatite come 
from the differences in material preparation techniques, time and temperature and 
medium. Powder processing, forming, and densification of HA have been understood 
quite well, allowing control of chemical composition and microstructures of both dense 
and porous HA Ceramics. 
 
 
Figure 3.1. Schematic of Crystal Structure of Hydroxyapatite (a) hexagonal, (b) 
monoclinic. 
 
3.1.1.Preparation of HA Powder 
 
Many techniques have been used for preparation of HA powders as reviewed in 
literature. There are two main methods for preparation of HA which are wet methods 
and solid-state reaction methods. In the case of HA production, the wet methods can be 
divided into three groups: precipitation, hydrothermal technique and hydrolysis of other 
calcium phosphates. Depending upon the technique, materials with various morphology, 
stoichiometry, and level of crystallinity can be obtained. Moreover, the properties of 
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HA powders depend on the preparation technique conditions that are starting materials, 
pH, temperature, aging time, and calcination conditions. 
Precipitation methods are commonly used ones in production of HA powder [7]. 
Rathje’s method consisted of drop wise addition of phosphoric acid, H3(PO4)2, to 
suspension of calcium hydroxide, Ca(OH)2 in water under stirring at room temperature. 
By this method, powders with different Ca/P ratio can be produced by changing the 
conditions (such as weight of solution and concentration) 
 
10 Ca(OH)2  3 H3(PO4)2  Ca10(PO4)6(OH)2  18 H2O 
 
This method is modified by addition of ammonium hydroxide, NH4OH, to keep 
the pH of the reaction very alkaline at about 11 to insure the formation of HA, to obtain 
the powder with Ca/P ratios in the range of 1.6-1.73 [7]. 
HA powders can also be prepared by using other starting materials through 
precipitation. A (NH4)2 HPO4 aqueous solution 200 ml (11.4 wt %) was slowly dropped 
into a stirred, 400 ml Ca(NO3)2 aqueous solution (16.8 wt %). The pH for both solutions 
was 10-12, adjusted with ammonium hydroxide, NH4OH and reaction was occurred at 
room temperature. After precipitation, slurry was put into an autoclave and 
hydrothermal treated at 140 0C and 0.3 MPa for 5 h. Finally, obtained slurry was dried. 
The Ca/P ratio of resultant HA powder were determined as 1.61 by an atomic 
absorption spectrophotometer. HA powders were rod-like particles with length between 
40-80 nm and the width between 20-40 nm. [35]. 
Ignjatovic and co-workers [8] investigated the synthesis of HA/Poly-L-Lactide 
composite biomaterials. In their study, HA powder was prepared by precipitation 
technique. A solution of (NH4)2HPO4  was added to solution of Ca(NO3)2 for 180 min 
and mixed by magnetic stirrer with rate of 100 rpm/min. The pH of the solution was 
held above 10 by adding ammonia due to stability of HA. The obtained suspension was 
heated to boiling, and the precipitate, being held in the starting solution for 18 h, was 
separated by filtration using Bihner’s funnel. After filtering, the resultant filter cake was 
washed with warm distilled water until the ammonia removed. After the obtained filter 
cake was dried in vacuum at room temperature, dried granules were calcined at 1100 0C 
for 6 h. The size of these granules was obtained in the range of 0.3-0.13 mm. The 
precipitation of HA powder was obtained according to the reaction given below; 
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pH10 
5 Ca(NO3 )2 + 3 (NH4)3PO4+ NH4 OH           Ca5 (PO4 )3 PO4+ 10 NH4 NO3 
 
In another study, Furukawa et al. [25,36] studied biodegradation behaviour of 
ultra-high-strength HA/ Poly(L-lactide) composite rods for internal fixation of bone 
fractures. Two types of synthetic HA were used as reinforcing particles in this study; 
calcined HA (c-HA) and uncalcined HA (u-HA). U-HA was produced by hydrolysis of 
pure calcium hydrogen phosphate and calcium carbonate by heating their aqueous 
solution at 90 0C. They were matured for 5 h and fully dried for 10 h after filtering. The 
chemical reaction is given below 
 
6 CaHPO4 + 4 CaCO3  Ca10(PO4)6(OH)2  4 CO2 +2 H2O 
 
The molar ratio of Ca/P by chemical analysis was 1.69 and very close to that of 
pure HA, which is 1.67. The particle size was limited within a range of 0.3-20 m. 
There are various preparation techniques used  the HA powder production such as 
flux method, electrocrystallization, spray-pyrolysis, freeze- drying, microwave 
irradiation, emulsion processing.   
 
3.1.2. Surface Modification of Hydroxyapatite 
 
Many kinds of fillers used for incorporation into polymers are treated with 
various surface modifiers in order to modify the characteristics of the filler matrix 
interface. Surface modification of the filler prevents the agglomerations of the particles 
by decreasing the strength of the interactions between particles. This way lead to 
improvements in the dispersion of the fillers during preparation and the mechanical 
properties of filled polymer composites [37]. 
Since modification of the filler changes the surface free energy of the filler, it 
effects on both particle-particle and particle-matrix interactions. Surface treatment 
causes the filler surface to become hydrophobic and moisture adsorption of particulate 
filled polymer composites is significantly reduced during storage inorganic fillers 
mostly contain OH group on the surface owing to reactions with atmospheric water. The 
hydrophilic nature of inorganic filler makes it’s easy for atmospheric water to 
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accumulate at interface by diffusing through matrix. As a result, interfacial bonds 
between polymers-filler are either weak or deterioratable on ageing, when composites 
exposed to humid environment. For this reason, the most of the time, the fillers are 
coated with coupling agents to form hydrophobic nature. A wide range of coupling 
agents has been used in particulate filled polymer composite [38]. 
Coupling agents are biofunctional molecules containing organic and inorganic 
ends improve mechanical properties and chemical resistance of composites by 
enhancing across polymer-filler interface. The most widely used coupling agents are 
silane and titanate based compounds whose chemical composition allows them to react 
with both the surface of filler and the polymer matrix. 
 
3.1.2.1. Silane Coupling Agents 
 
The general formula of silane coupling agents is Y (CH2) n Si (OR)3, where R 
stands for most frequently methyl, ethyl or isopropyl group while Y denotes a 
functional group capable of interaction with polymers such as  amino, mercapto or vinyl 
group. The modification reaction on the filler develops as follow [39]. 
 
Hydrolysis reaction 
Y (CH2) n Si (OR) 3 +3H2O    Y (CH2) n Si (OH) 3 + 3 ROH 
Condensation Reaction 
Si-OH + (OH)3 Si (CH2)n Y   Si-o-Si (CH2)n Y + H20 
 
 The presence of water in the system is one of most significant parameters in the 
reaction water molecules cause hydrolysis and formation of silanols (Si-OH). Silanols 
can be combined to form of siloxane linkage (Si-O-Si) between two silane molecules 
and production of a new water molecule. The formation of siloxane group allows the 
bonding of the coupling agent with filler. Commonly used silane coupling agents are 
listed in Table 3.1. 
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Table 3.1 Commonly Used Silane Coupling Agents. 
Silane Coupling Agents Chemical Formula 
(3-methacryloxypropyl)trimethoxy silane CH2=C-CO-O-CH2-CH2-CH2-Si- 
(O-CH3)3CH3 
(3-aminopropyl)triethoxy silane NH2-CH2- CH2- CH2-Si-(O- CH2-CH3)3 
Vinyl triethoxysilane CH2=CH-Si-(O- CH2-CH3)3 
(3-mercaptopropyl)trimethoxy silane HS- CH2- CH2-Si-(O- CH3)3 
 
  Dupraz et al. [13] focused on the coupling agent as a coating on the HA 
powder’s surface in their study. Investigations have been performed to select an 
appropriate silane with regard to its ability to achieve a stable coverage the of HA 
particles. To ensure a uniform coverage of the HA surface, silane coupling agents were 
applied from an aqueous alcohol solution. Depending on the molecular structure of the 
silane, different times were allowed for hydrolysis and silanol formation. The silanized 
powders were dried at room temperature to improve the stability of the coating and then 
heated at 100-120 0C to strengthen the coating by polysiloxane network structures. 
They found that silane coupling agents were able to bond chemically of the HA 
surface because of a thin coating remained after washing powder with water. The water 
stability of this bond was evaluated and aminofunctional silane was found to be most 
effective one among the others used. And the presence of the silane coatings on HA did 
not impair the minerals’tendency to dissolve partly in water or to take up calcium and 
phosphate from simulated physiological solutions.  
The treatment of HA has received little attention in literature for biopolymer-
ceramic composite systems. Vaz et al [38] studied the surface modification of HA 
coupling agents for starch EVOH/HA composite system to improve mechanical 
properties of the composites. Significant improvements were obtained in modulus about 
30% increase when using zirconate-coupling agent. 3-Aminoproplymethyl 
timethoxysilane also enhanced stiffness of composites to about 30%. But composites 
rapidly lose strength and stiffness when exposed to an aqueous environment. All 
composites containing coupling agent should be tested in terms of cytotoxic behaviour, 
if they will be used for biomedical applications. 
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3.2. Biodegradable Polymers 
 
 
Using of biodegradable polymeric biomaterials have increased irregularly during 
the past two-decade. The total US revenues from commercial products developed from 
absorbable polymers in 1995 was estimated to be over $300 million with over 95% of 
revenues generated from the sale of bioabsorbable sutures. The other 5% is attributed to 
orthopedic fixation devices in the forms of pins, rods and tacks, staples for wound 
closure, and dental applications [40]. Biodegradable polymeric devices have some 
advantages that non-biodegradable material do not have [25]. 
 No need operation for removal 
 No restriction of one growth owing to the gradual decrease in mechanical 
strength  
 No tissue reaction caused by metallic corrosion 
 No generation of artifacts on computed tomography 
 To be able to regenerate tissues 
 
Although the earliest and most commercially significant biodegradable 
polymeric biomaterials originated from linear aliphatic polysters such as polyglycolide 
and polyactide from poly (-hydroxyacetic acids), recent introduction of several new 
synthetic and natural biodegradable polymeric biomaterials extends the domain beyond 
this family of simple polyesters. These new commercially significant biodegradable 
polymeric biomaterials include poly (orthoesters), polyanhydrides, polysaccharides, 
poly(ester-amides), tyrosine-based polyarylates or polyiminocarbonates or 
polycarbonates, poly (D, L-Lactide-urethane), poly (-hydroxybutyrate), poly(-
caprolactone) ,poly(bis(carboxylatopheneoxy) phosphazene), poly(amido acids), 
pseudo-poly (amino acids) and copolymers derived from amino acids and nonamino 
acids. 
The factors that affect the mechanical performance of biodegradable polymers are 
those that are well known to the polymer scientist. These factors are monomer selection, 
initiator selection, process conditions, and the presence of additives. These factors in 
turn influence the polymer's hydrophilicity, crystallinity, melt and glass transition 
temperatures, molecular weight, molecular weight distribution, end groups, sequence 
distribution (random versus blocky), and the presence of residual monomer or additives. 
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[40] In addition, the polymer scientist working with biodegradable polymers must also 
evaluate each of these variables for its effect on biodegradation. Table 3.2 indicates 
properties of synthetic absorbable polymers.  
Biodegradation polymeric biomaterials could be generally divided into eight 
groups based on their chemical origin [3]. 
1. biodegradable linear alipathic polyesters (e.g. polyglycolide, polylactide, 
polycaprolactone and their copolymer within the aliphatic polysters family 
such as poly (glycalide-L-lactide copolymer) 
2. biodegradable copolymer between linear alipathic polyesters and monomers 
other than linear alipathic polyesters (e.g. poly(L-lactic acid-L-Lysine) 
copolymer, poly  (e.g. (D-L-lactide urethane)copolymer) 
3. polyandhydrides 
4. polylorthoesters 
5. poly (ester-ethers) like poly-dioxanone 
6. biodegradable polysaccharides 
7. polyamino acids (such as poly-L-glutamic acid and poly-L-lysine) 
8. inorganic biodegradable polymers (such as polyphosphazene) 
The polymers used in this study come from the group 1, linear aliphatic family 
which are Poly (L-Lactide) and Poly (L-Lactide-DL- Lactide) copolymer. Next section 
presents the information about them. 
 
3.2.1.Polylactide and its copolymer 
 
Lactide is the cyclic dimer of lactic acid, which exists two optical isomers, D and 
L. Lactide, is the naturally occurring isomer, and DL-Lactide is synthetic blend of solid 
state through ring-opening polymerization due to their thermal instability and should be 
melt processors at the lowest temperature [24]. Figure 3.2 indicates synthesis of 
Polylactide. 
 
 
 
 
Figure 3.2 Synthesis of Polylactide [40]. 
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The homopolymer of L-lactide (PLA) is a semicrystalline polymer with melting 
temperature, Tm, 170 0C and glass transition temperature, Tg, 560 C. This high Tg is 
mainly responsible for the observed extremely slow biodegradation rate at body 
temperature reported in the literature [40].  PLA exhibit high tensile strength and low 
elongation and have a high modulus that makes them more applicable than amorphous 
polymers for load-bearing applications such as in orthopaedic fixation. 
The polymer made from optically inactive racemic mixture of D and L 
enantiomers, poly-DL-Lactide is an amorphous polymer. This material has lower tensile 
strengths and higher elongation and much faster degradation time making it more 
suitable as a drug delivery system. Physical, mechanical and degradation properties of 
selected biodegradable polymers and comparison with bone and steel as reference 
materials are summarised in Table 3.2 [40]. Consequently, devices prepared from PLA 
should biodegrade less rapidly than devices prepared from racemic PDLA. 
 
Table 3.2. Physical, Mechanical and Degradation Properties of Selected Biodegradable 
Polymers. 
Polymer Tm(0C) Tg(0C) Modulus(GPa) Elongation (%) td(months) 
PGA 225-230 35-45 7.0 15-20 6 to 12 
PLA 173-178 60-65 2.7 3-10 24 
PDLA Amorphous 55-60 1.9 3-10 12 to 16 
PCL 85/15 58-63 60-65 0.4 300-500 24 
DLPLG 
65/35 
Amorphous 50-55 2.0 3-10 5 to 6 
DLPLG 
50/50 
Amorphous 45-50 2.0 3-10 4 to 5 
DLPLG Amorphous 45-50 2.0 3-10 3-4 
Bone   10-20   
Steel   210   
 
Tm : Melting Point 
Tg :Glass Transition Temperature 
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3.3. HA Reinforced PolyLactide Based Composites 
 
Development of the HA reinforced polylactide based composites has been studied 
extensively in the literature. Next sections focus on the literature review of the 
preparation techniques and characterization of the Polylactide-HA composites. 
 
3.3.1. Preparation Techniques  
 
There are many different techniques used according to application area and the 
properties needed for preparation of this composite in the literature: solvent casting, [8, 
9, 12, 25, 35] thermal kneading, heating mortar, [41] mixing ceramic powder before 
polymerization [6, 10] and phase separation [42, 43]. After these techniques, 
compression molding has been widely applied to give a form.  
Ignjatovic et al [8] investigated the preparation of HA / Poly(L-Lactide),(PLA), 
composites by solvent casting technique. HA and PLA were synthesised chemically. 
PLA was completely dissolved in chloroform at 20 0C for 1 h. HA powder was added to 
PLA solution, and the mixture was stirred at 20 0C for 20 min. After homogenisation, 
the mixture was poured into molds, then heated in a vacuum drying oven at 400C until 
complete evaporation of chloroform. Pressing in cylindrical molds shaped the obtained 
HA/ PLA composite biomaterial. In their study, effect of mass fraction of HA in the 
composite on the mechanical properties has been studied. 
Preparation and mechanical properties of PLA composites containing HA fibers 
have been examined in another study [9], 10 g PLA was soaked in 100 ml of methylene 
chloride at room temperature. After soaking for 24 h, PLA was dissolved completely. 
HA fiber was added to PLA solution and the mixture was stirred for 30 min.  The 
mixture was cast into a stainless steel die of 38-mm diameter and was dried for 8 h at 
room temperature. Hot-pressed uniaxially was applied to give a form at 180 0C under a 
pressure of 40 MPa. 
Shikinami and co-workers [25] examined ultra high strength resorbable implants 
that were made from bioactive ceramic particles/PLA composites. The small granules 
uniformly distributing HA microparticles within a PLA matrix which were obtained by 
precipitating polymer solution, dropping ethanol into dichloromethane-polymer 
solution, were extruded to make a thick billet. Thereafter, the billet was formed into a 
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thin billet by compression molding at 103 0C. The composites were filled with 20,30,40 
and 50 weight fractions of HA particles. 
Zhang and Ma investigated [42,43] Poly (-hydroxyl acids)/HA porous 
composites for bone-tissue engineering. Poly ( L-lactic acid ) and Poly ( D,L-lactic acid-
co-glycolic acid; 75/25) (PLGA) polymers were used in the study. To prepare the 
composite, firstly PLA or PLGA was dissolved completely in dioxane and mixed HA 
homogeneously. After preparation of polymer-HA mixture, thermally induced phase 
separation and subsequent sublimation of solvent prepared composite foam. Thermally 
induced phase separation technique was used to create the highly porous scaffolds for 
bone tissue engineering. Varying polymer concentration controlled the microstructure of 
the foams. 
Deng et al [35] studied nanocomposite production of PLA/HA composites. These 
composites were prepared through solvent-cast technique. But this preparation method 
was different from the others. First, HA powder was dispersed in solvent, which is 
dimethyl formamide (DMF), using ultrasonics for 30 min. The dispersion was filtered 
for removal of large aggregates. Pre-weighted PLA was added into a flask that 
contained HA powder. PLA then totally dissolved into the sol. The resulting mixture 
was poured into mould and dried under vacuum. 
Bleach and co-workers [12] examined effects of filler content on mechanical 
properties of biphasic calcium phosphate (BCP)/PLA composites. BCP consisted of a 
mixture of 70 wt % -TCP and 30 wt % HA. Solvent casting technique was used to 
produce composite films. 
In another study, Kikuchi et al [41] studied preparation of calcium phosphate/ 
copoly-L-Lactide(CPLA) with fatty polyesters composites. They synthesised 
composites using three different methods. 
1) Solvent Casting Method; A calcium phosphate powder was added into a chloroform 
solution of copoly-L-Lactide and dried at 293 K in vacuum.  
2) Heating mortar Method; CPLA was put in a mortar and heated at 453 K for 30 min. 
Calcium phosphate also heated at the same temperature, and mixed with melted 
CPLA for 15 min. After mixing, the composite was removed from the mortar and 
cooled at room temperature. 
3) Thermal kneading Method; Mixture of CPLA and calcium phosphate was kneaded 
for 10 min at 20-50 rpm at 453 K. 
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These three types of composites were formed into plates by thermal pressing. 
Finally thermal-kneading method was found to be better than the other preparation 
methods. The other method used for the production of polymer- ceramic composite is 
based on mixing of ceramics with monomers prior to polymerization.[6,10] Appropriate 
weight by weight mixture of D-lactide monomer and hydroxyapatite (0,30,50 wt % ) 
were heated to 105 oC in rotating vacuum sealed ampules for 72 h. Stannous octoate 
was used as a catalyst to initiate the polymerization. 
 
3.3.2. Characterization of Polylactide based HA Composites 
 
In literature, different characterization techniques were employed to understand 
the mechanical, physicochemical and morphological properties of the composites 
 
3.3.2.1. Mechanical and Microstructural Characterization 
 
The complete mechanical characterisation of composite is achieved using 
mechanical and viscoelastic analysis. Measurements of the elastic and viscoelastic 
components of the modulus characterise the material. And also knowledge of the values 
of resistance to deformation and fatique is important in selecting a material. Mechanical 
tests have been standardised and are described in the publications of American Society 
for Testing and Materials (ASTM). The tests are defined to obtain about the final end 
use performance. Mechanical properties of composites are affected by many factors, 
such as, filler loading, homogeneous dispersion of filler, preparation technique and 
conditions. Tensile strength, Young modulus, yield stress, ultimate elongation are 
generally used to characterise the mechanical properties of the composites. Young’s 
Modulus is the ratio of stress to strain below the elastic limit, gives information about 
rigidity of the composite. Tensile yield stress is very important property of the 
composites, gives information on the maximum allowable load before plastic 
deformation occurs. 
Microscopy techniques such as optical, transmission and scanning electron 
microscope are useful as analysis technique, particularly in the case of morphological 
structure of composites. Optical Microscopy and scanning electron microscopy (SEM) 
give information about the state of dispersion of particles in the polymer matrix and 
effects of surface treatment on the fillers. Optical microscopy is of limited value in 
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examining the interface region. For this reason electron microscopy, which has 
resolutions to several nanometers, is used to study details of especially fracture surface.  
 Mechanical and microstructural properties of polyLactide based HA composites 
have been investigated in literature.  
Kikuchi and co-workers [41] investigated effects of calcium phosphate type, 
tricalcium phosphate (TCP) and hydroxyapatite (HA) and preparation technique 
(Chloroform- solvent method, Heating mortar method, Thermal kneading method) on 
the mechanical properties of calcium phosphate/ copoly-L-Lactide (CPLA) composites. 
TCP/CPLA and HA/CPLA composites prepared by the thermal kneading method were 
the most homogeneously dispersed without colouring.  TCP/CPLA composites had 
better mechanical properties and thermoplasticity than HA/CPLA. Especially, Young’s 
modulus was improved by strong adhesion between TCP and CPLA. In their study,  
SEM images showed HA particles were not well covered with CPLA although the 
primary particle size of HA was smaller than that of TCP. On the other hand, in 
TCP/CPLA composites, CPLA formed a homogeneous dispersion and covered TCP 
particles well.  
Kasuga et al. [5] examined preparation of bioresorbable poly-L-lactic acid 
(PLLA) composites containing -Ca (PO3)2 fibers (CPF and CPFt) treated with dilute 
NaOH solution. PLLA dissolved by using methylene chloride was mixed with the 
fibers. The strength of PLLA/ CPF decreased with increasing the fiber content, while 
that of PLLA/ CPFt was almost independent of the content. The modulus of PLLA/CPF 
composite increased with increasing CPF content up to 20 wt %, and then decreased 
when the fiber content was over 35 wt%. On the other hand, the modulus of PLLA/ 
CPFt increased monotonously with increasing the fiber content. Their study showed that 
the fiber surface modification with dilute NaOH was essential for the preparation of the 
PLLA composites. The calcium orthophosphate phase on the surface of the fiber formed 
by the NaOH treatment was believed to be linked chemically with PLLA. 
The preparation and mechanical properties of nanocomposites of Poly (D,L-
Lactide) with Ca-deficient HA nanocrystals were examined by Deng and co-
workers.[35] Nanocomposites were prepared by solvent casting technique using 
dimethylformamide. The obtained nanocomposites are semitransparent films with the 
thickness about 0.1 mm. The microstructural observation indicates close contact 
between the polymer matrix and the filled nanocrystals. The dispersion of nanocrystals 
in the polymer matrix is homogeneous at a microscopic level. The relationship between 
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the HA particles loading and tensile modulus for HA/ PLA composites has been 
investigated in their study. For the composite containing 10.5 v % HA, the modulus 
even reaches to 2.47 GPa as compared to 1.66 GPa for pure PLA. Tensile modulus for 
composite increases with HA loading. Yield stress for the composites varies irregularly 
with HA loading.  
Bleach and coworkers [12] investigated effect of filler content on mechanical 
properties of bicalcium phosphate(BCP)/polylactide composites. Adding ceramic 
particles to the polymer increased the modulus and yield stress. In addition, modulus 
and yield stress were maintained over a 12-week in vitro period when filler particles 
were added to the composite a significant decrease in modulus and yield strenght at 12 
week. In the composite, all the elongation arises from the polymer since the BCP is 
rigid relative to the PLA. Increasing the amount of filler decreases the amount polymer 
available for elongation and reduces the failure strain. Following preparing the 
composite, preliminary tests using DSC showed that the cast films representing all BCP 
were free from crystallinity. The morphological structure of BCP particles in the 
composite films was investigated in their study. Scanning electron Microscopy showed 
a homogeneous distribution of BCP particles in the films, which were a maximum of 50 
m thick. However some agglomeration was seen in the composites containing larger 
volume fractions of BCP.  
Poly (-hydroxyl acids)/ hydroxyapatite porous composites for bone tissue 
engineering were prepared by thermally induced phase separation technique [42]. The 
microstructure of the pores and walls was controlled by varying the polymer 
concentration, HA content, quenching temperature, polymer and solvent utilized in their 
study. The composite foams showed a significant improvement in mechanical properties 
over pure polymer foams. Both compressive modulus and the compressive yield 
strength of the composite foams are significantly higher than those of the PLLA foam. 
The mechanical properties data showed the positive effects of the addition 
hydroxyapatite in enhancing the mechanical performance of the foams. 
Shikinami et al [25] studied preparation and characterization of HA / PolyL-
Lactide composites. The composites were prepared by forging process.  Uncalcined and 
unsintered HA (u-HA) was used as filler in their study. Effect of u-HA loading on the 
mechanical properties of u-HA / PLA was investigated. Mechanical properties of these 
composites as a function HA loading were given in Table 3.3. The gradual decrease in 
tensile strength was inversely proportional to the fraction of HA particles, but a high 
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enough tensile strength of over 100 MPa was maintained and this was sufficient for 
practical use as bone fixation devices. It was confirmed that the composites generally 
showed the highest mechanical strenght among this type of reinforced bioceramic 
particles or fibers- biopolymer composites known to date. The high bending, shear, and 
impact strengths and the high bending modulus of these composites were found to be 
very dependent on the mechanical interlocking between the HA particles and PLA 
matrix.  
  
Table 3.3 Effects of u-HA Contents on the Mechanical Properties of u-HA / PLA. 
Mechanical 
Properties 
PLA u-HA 
20 
u-HA 
 30 
u- HA 
40 
u-HA 
50 
HA/PLA 
Ratio(wt) 
0/100 20/80 30/70 40/60 50/50 
Mv (K Da) 220 215 210 208 202 
Sb (MPa)    258.5 252.2 269.2 270 267.5 
Eb (GPa ) 6.5 7.0 7.6 9.1 12.3 
St (MPa) 154.1 152.8 121.5 110.0 103.0 
Et (GPa ) 1.3 2.0 2.3 2.3 2.4 
Sc (MPa) 123.5 144.5 106.7 107.3 115.3 
Ec (GPa) 4.8 5.3 5.6 6.1 6.5 
Ss (MPa) 93 127.2 126.4 127.6 143.6 
Ts (kg.cm) 6.6 6.8 6.6 6.0 4.0 
SI (kj/cm2) 76.3 ND 166.1 90.9 30.2 
Hv  20.2 20.8 22.9 23.8 26.3 
Mv; viscosity avr. Molecular weight, Sb; bending strength, Eb; bending modulus, St; tensile 
strength, Et; tensile modulus, Sc ; compressive strength, Ec ; compressive modulus, Ss ; shear 
strength, Ts ;torsional strength, SI; impact strength, Hv; vickers hardness 
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Chapter 4 
 
 
DEGRADATION OF POLYMER CERAMIC COMPOSITE 
 
The term biodegradation is frequently loosely associated with materials that 
could be broken down by nature either through hydrolytic mechanisms without the help 
of enzymes and/or enzymatic mechanism. Other terms, such as absorbable, erodible and 
resorbable have also been used in the literature to indicate biodegradation. The interest 
in biodegradable polymeric biomaterials for biomedical applications has increased 
dramatically during the past decade. 
Why would a medical practitioner want a material to degrade? There may be a 
variety of reasons, to have advantages. For example, a fractured bone, fixated with a 
rigid, non-biodegradable stainless a device, which can be used as an implant and will 
not necessitate a second surgical event for removal. In addition to not requiring a second 
surgery, the biodegradation may offer other steel implant, has a tendency for re-fracture 
upon removal of the implant. The bone does not carry sufficient load during the healing 
process, because the load is carried by the rigid stainless steel. However an implant 
prepared from biodegradable polymer can be engineered to degrade at a rate that will 
slowly transfer load to the healing bone. Another exciting application for which 
biodegradable polymers offer tremendous potential is the basis for drug delivery, either 
as a drug delivery system alone or in conjunction to functioning as a medical device. In 
orthopedic applications, the delivery of a bone morphogenic protein may be used to 
speed the healing process after a fracture, or the delivery of an antibiotic may help 
prevent osteomyelitis following surgery [40]. 
There are different types of polymer degradation such as photo, thermal, 
mechanical and chemical degradation. All polymers share the property that they erode 
markedly under the influence of UV light or -radiation. For polymeric biomaterials, 
such effects are of minor importance, unless they are subjected to -sterilisation, after 
which a significant loss of molecular weight can be observed. Thermal degradation 
plays a greater role for non-degradable polymers. Mechanical degradation affects those 
biodegradable polymers that are subjected to mechanical stress, such as non-degradable 
polymers or biodegradable polymers used as fixture or suture material. All 
biodegradable polymers contain hydrolysable bonds. Their most important degradation 
mechanism is therefore chemical degradation via hydrolysis or enzyme-catalysed 
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hydrolysis. The latter effect is the degradation mediated at least partially by a biological 
system. Polymer degradation is the key process of erosion. There are two principal ways 
which polymer can cleave bonds: passively by hydrolysis or actively by enzymatic 
reaction. The latter option is only effectively available for naturally occurring 
biopolymers like polysaccharides, proteins (gelatin and collagen) and poly (-hydroxy 
acids) where appropriate enzymes are available. For most, biodegradable materials, 
especially artificial polymers, passive hydrolysis is the most important mode of 
degradation [44]. 
There are several factors that influence the speed of this degradation reaction: 
the type of chemical bond, pH, copolymer composition, temperature and water uptake 
are the most important factors. Chemical and physical changes go along with the 
degradation of biodegradable polymers, like the crystallisation of oligomers and 
monomers or pH changes. Some of these factors can have a substantial feedback effect 
on the degradation rate. The most important parameter for monitoring degradation is 
molecular weight change. Besides loss of molecular weight, other parameters have been 
proposed as a measure for degradation into monomers or monomer release. All of these 
are related need not necessarily obey the same kinetics. For example, complete 
degradation of poly (L-lactic acid) is known to take substantially more time than the 
loss of tensile strength. Aqueous solutions of lactic acid form spontaneously poly (lactic 
acid) oligomers that might affect molecular weight measurements and monomers from 
copolymers need to be released with identical kinetics during erosion. The specific 
relation between the erosion parameters varies according to the type of polymer. There 
are, however, basic principles, according to which degradation proceeds, and how 
degradation can be influenced [45]. 
In general, for most synthetic biodegradable polymers degradation is considered 
to be a hydrolytic process. The cleavage of an ester bond yields a carboxyl end group 
and a hydroxyl one. Thus, the formed carboxyl end groups are capable of catalysing 
hydrolysis of other ester bonds. This phenomenon is called as autocatalysis [46]. 
There are two main types of degradation: Bulk erosion and Surface erosion. 
Bulk erosion occurs when the rate at which water penetrates the device exceeds 
that at which the polymer is converted into water-soluble materials. The polylactide and 
polyglycolide commercially available devices and sutures degrade by bulk erosion [40]. 
The degradation rate at the surface of large lactide-glycolide implants is slower than the 
degradation in the inside. Initially, degradation does occur more rapidly at the surface 
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due to the greater availability of water. The degradation products at the surface are 
rapidly dissolved in the surrounding fluid and removed from the bulk polymer. In the 
inside of the device the inability of large polymeric degradation products to diffuse 
away from the bulk device results in a local acidic environment in the interior of the 
implant. The increased acidic environment catalyses further degradation resulting in 
accelerated hydrolysis of the ester linkages in the interior. 
There is a second type of biodegradation called surface erosion when the rate at 
which the polymer penetrates the device is slower than the rate of conversion of the 
polymer into water-soluble materials [44]. Surface erosion results in the device thinning 
over time while maintaining its bulk integrity. Polyanhydrides and polyorthoesters are 
examples of this type of erosion when the polymer is hydrophobic, but the chemical 
bonds are highly susceptible to hydrolysis. In general, this process is referred to in the 
literature as bioerosion rather than biodegradation. 
The morphology of a polymeric material (ie, amorphousness or semicrytallinity) 
plays a critical role in the degradation process. Chain orientation in crystalline and 
amorphous regions could also play an important role in the degradation of polymers.  
The semicrystalline polymers of degradation occur in two phases: 
In the first phase, water penetrates the bulk of the device, preferably attacking the 
chemical bonds in the amorphous phase and converting long polymer chains into 
shorter, finally water-soluble fragments can be occurred. A decrease in physical 
properties as water begins to fragment the device follows the decrease in molecular 
weight. In the second phase, enzymatic attack of the fragments occurs. The 
metabolising of the fragments results in a rapid loss of polymer mass. 
The degradation-absorption mechanism is the result of many interrelated factors, 
including: 
 the chemical stability of the polymer backbone, 
 the presence of catalysts, 
 additives, 
 impurities or plasticisers, 
 the geometry of the device,  
 the location of the device. 
The balancing of these factors to tailor an implant to slowly degrade and transfer 
stress to the surrounding tissue as it heals at the appropriate rate is one of the major 
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challenges facing the researchers today. The factors, which accelerate polymer 
degradation, are the following: 
 More hydrophilic monomer. 
 More hydrophilic, acidic end groups. 
 More reactive hydrolytic group in the backbone. 
 Less crystallinity. 
 Smaller device size.  
 
4.1.Hydrolytic Degradation of Polylactide Polymers and Polylactide Based 
Composites Containing Hydroxyapatite  
 
The in vivo and in vitro degradations of polylactide and its copolymers have 
been extensively investigated during the past two decades. [47-50] 
PolyLactide (PLA) is aliphatic polyesters that contain flexible ester bonds in 
particular appear to be the most promising because of their excellent biocompatibility 
and variable degradability. It was established that carboxyl end groups formed by chain 
cleavage and amorphous regions are preferentially degraded faster than crystalline 
regions. 
Since PLA is a semicrystalline polymer, the effect of crystallinity on the 
degradation rate should be examined, Li investigated the degradation rate of both 
amorphous and crystalline PLA in order to examine the influence of the initial 
crystallinity on the degradation rate [46]. In the semicrystalline PLA, a small weight 
loss was detected after 7 weeks, which was earlier than in amorphous PLA. At the end 
of the 110 weeks, only 26% of the material were lost. Therefore, the crystallinity 
reduced the overall degradation rate of PLA in terms of weight loss. 
Cha et al. [51] studied the effect of sample preparation techniques on the 
biodegradation properties of Poly(-caprolactone) (PCL), Poly( L- lactic acid) (PLA), 
Polyglycolic acid-co-L-lactic acid (PGLA). Three different methods; compression 
mouldings, coprecipitation, and solvent evaporation of methylene chloride in water 
emulsion of the polymers were used for the preparation of the polymers. The rates of 
hydrolytic chain of each component of the blends were determined in phosphate buffer, 
pH 7.4, at 37 0C, for up to 3000 h. The observed rates were dependent on the 
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preparation method. For compression moulded blends, the rate of degradation PGLA 
was decreased and that of PCL and PLA increased. 
Furukawa et al [36] investigated the biodegradation behaviour of ultra-high 
strength hydroxyapatite/ poly (L-Lactide) composite rods for internal fixation of bone 
fractures. The biodegradation of the composite rods in subcutis and medullary cavities 
of rabbits were evaluated were prepared histologically. Two kinds of composite 
materials were prepared using uncalcinated and calcinated HA as reinforcing filler in 
their study. A bending strength higher than 200 MPa were maintained at 25 weeks in 
the subcuits. 
Greish et al [31] investigated the effects of the addition of a bioactive glass to 
Ca-polyacrylate in ratios up to 50% by weight on the mechanical and the 
microstructural properties of HAp-Ca-polyacrylate-bioactive glass composites. The 
behaviour of these composites in Simulated Body Fluid (SBF) revealed an apatite layer 
formed on the surface of the bioactive glass. This was in accordance with the changes in 
the ionic concentrations of the calcium, phosphorous and silicate ions in the SBF. 
Verheyen et al [6] examined the physico-chemical behaviour of hydroxyapatite/ 
poly (L-lactide) composites in the tests solution. The polymer PLA, the composites 30 
wt % and 50 wt % HA/PLA and one- side HA-coated PLA were evaluated. Specimens 
were incubated in various acellular aqueous buffer solutions; citrate, Gomori’s and 
phosphate- buffered saline up to 24 weeks. HA/ PLA composites with 30 or 50 wt % 
HA showed linear release of calcium and phosphate ions and L-Lactide when incubated 
into different buffers within the tested incubation period of 24 weeks at pH of 7.2.  In 
this study in vitro results showed that solubility of calcium phosphates is not only 
dependent on the surrounding medium, but also the material itself. 
Higashi et al. [11] have combined poly (DL-Lactide) with HA in a 1:1 ratio to 
develop biodegradable artificial bone fillers where high mechanical strength is not 
required in the composites. They investigated biodegradation behaviour of the 
composites tested both in vivo and in vitro. Degradation studies were done in a distilled 
water medium at 37 0C and pH 6.8. pH measurements, calcium and phosphorous 
concentration determinations were done for each specimen. It was reported that 
Hydroxyapatite showed a very slight increase in pH level with time. On the other hand 
HA/PLA composite became acidic, and pH level reached to 3.4 value in a one week.  
The pH level in vivo does not decrease as much as that in vitro because of the buffer 
action mechanism. 
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Shikinami et al [52] investigated the change of bending strength of HA/PLA 
composite by degrading in vitro in phosphate buffered saline (PBS) solution having the 
pH value of 7.4 at 37 0C and the bonding osteointegration ability of the composite to 
bone in simulated body fluid (SBF) at 37 0C. In Vitro bioactivity tests showed that 
generous apatite crystals began to form on the surface of the composite after 3-6 days in 
SBF and covered the whole surface with a fairly thick layer after 4 weeks. The apatite 
deposition may lead to bond a device to bone at the beginning in vivo, and then to 
reduce a bone hole due to both degradation and resorption of PLA by replacing with the 
surrounding tissues. 
Marra et al [53] studied the degradation rates of HA/Poly (caprolactone) and 
HA/ Poly (D,L-lactic-co-glycolic acid) in vitro for applications in bone tissue 
engineering. Weight loss during storage at 37 0C in phosphate-buffered saline (pH 7.4) 
was determined for specimens. The buffer solution was changed every 2 weeks. The 
weight loss of the composites over an 8-week period was determined by gravimetric 
analysis. 10-50 wt % weight loss was observed. 
Zang and Ma [42, 43] investigated the highly porous poly (L-lactic acid)/ apatite 
composites were prepared through in situ formation of carbonated apatite onto poly (L-
lactic acid) foams in simulated body fluid. The highly porous polymer foams were 
prepared by solid liquid phase separation. The foams were immersed in the SBF at 37 
0C to allow the in situ apatite formation. After 30 days, a large number of microparticles 
with a diameter up to 2 m was formed on the surfaces of the PLA pore walls. The EDS 
spectrum showed that the main elements of the incubated PLLA foam were carbon, 
oxygen, calcium and phosphorus. Carbon and oxygen could be from both PLA and the 
particles but calcium and phosphorus could only be from the particles. These results 
suggested that the particles formed in the PLA foams might be similar to HA. The film  
surfaces were completely covered with microparticles after 15 days of incubation. The 
particle number and size were affected by several factors such as incubation time, ionic 
concentration of the SBF, water treatment and polymer surface area. 
As for the in vitro studies, many types of environment such as phosphate buffer 
solution, saline solution, ringer solution and simulated body fluid can be used These 
solutions can be prepared at different conditions, such as pH, temperature and so on. 
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4.2. Simulated Body Fluid 
 
SBF is known to be as metastable buffer solutions [54], and even a small, 
undesired variance in both preparation steps and storage temperatures, may drastically 
affect the phase purity and high-temperature stability of the produced HA powders, as 
well as the kinetics of the precipitation processes. 
It is believed that synthetic HA ceramic surfaces can be transformed to 
biological apatite through a set of reactions including dissolution, precipitation and ion 
exchange. Following the introduction of HA to simulated body fluid, a partial 
dissolution of the surface is initiated, causing the release of Ca+2, HPO4-2 and PO3-3 and 
increasing the supersaturation of the environment with respect to stable phase. A 
hydroxy-carbonate apatite (HCA) layer can form with calcium and phosphate ions 
released from partially dissolving ceramic HA and from biological fluids, which contain 
other electrolytes, such as CO3-2 and Mg+2. This polycrystalline HCA phase is 
equivalent in composition and structure to mineral phase of bone.  
Protocol for the preparation of Simulated Body Fluid (SBF) having ion 
concentrations nearly equal to those of human blood plasma which is buffered at pH 
7.40 with 50 mM trishydroxymethylaminomethane and 45 mM hydrochloric acid at 
36.5 0C. After washing SBF solutions were prepared by dissolving appropriate 
quantities of the chemicals given in Table 4.1 in deionised water. Reagents were added, 
one by one after each reagent was completely dissolved in 700 ml of water, in the order 
given in Table 4.1 [55].  
Synthetic (simulated) body fluids (SBF) were first used by Kokubo et al. [54] 
The solutions can be prepared to the identical chemical compositions of human body 
fluid, with ion concentrations nearly equal to those of the inorganic constituents of 
human blood plasma. And also they proved the similarity between in vitro and in vivo 
behaviour of certain glass-ceramic compositions. Table 4.2 indicates the ionic 
concentrations (mM) of SBF in comparison with those of and bloods plasma. 
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Table 4.1 Reagents Used for the Preparation SBF (pH 7.4, 1 L). 
Order Reagent Amount 
1 
2 
3 
4 
5 
6 
NaCl 
NaHCO3 
KCl 
K2HPO4.3H2O 
MgCl2.6H2O 
1N-HCl 
 
7.996 g 
0.350 g  
0.224 g 
0.228 g 
0.305 g 
40 mL 
(About 90% of total amount of HCl to be added) 
7 
8 
9 
CaCl2 
Na2SO4 
NH2C(CH2OH)3 
  0.278 g 
  0.071 g  
  6.057 g 
 
 
Table 4.2. Ion Concentrations (mM) of SBF and Human Blood Plasma. 
Ion Simulated body fluid Blood plasma 
Na+ 
K+ 
Mg2+ 
Ca2+ 
Cl- 
HCO3- 
HPO42- 
SO42- 
142.0 
5.0 
1.5 
2.5 
147.8 
4.2 
1.0 
0.5 
142.0 
5.0 
1.5 
2.5 
103.0 
27.0 
1.0 
0.5 
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Chapter 5 
 
EXPERIMENTAL 
 
5.1. Materials 
 
Polymeric materials used in this study were Polylactide and their copolymers 
purchased from PURAC Biochem and Boehringer Ingelheim. The properties of four 
different polymers used in this study are listed in Table 5.1. Two different types of 
Hydroxyapatite powders (HA) were used; commercial HA and laboratory synthesized 
HA. Commercial HA powder was purchased from Aldrich Chemical Company. In 
Table 5.2 the properties of the commercial hydroxyapatite are listed. Chloroform was 
used as a solvent for the preperation of polymer solution. The properties of the solvent 
are given in Table 5.3. 
 
Table 5.1. Properties of the Polymers Used in This Study. 
Polymers 
 
Inherent Viscosity Melting 
Temperature 
*Poly(L-Lactide) (PLA1) 1.75 dl/g 170-200 0C
*96/4 L-Lactide/D-Lactide 
copolymer (PDLA1) 
5.68 dl/g amorphous 
**Poly(L-Lactide) (PLA2) 3.6 dl/g 172-195 0C 
**Poly(L-Lactide-co-D,L-lactide) 
(PDLA2) 
6 dl/g amorphous 
* purchased from PURAC 
** purchased from Boehringer Ingeltheim 
 
Table 5.2. Properties of Commercial Hydroxyapatite. 
Chemical Formula Ca10 (PO4)6 (OH)2 
Molecular Weigth (g/mol) 1004.6 
Density (g/ cm3) 3.16 
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Table 5.3. Properties of Chloroform. 
Chemical Structure CHCl3 
Molecular Weight (g/ mol) 119.38 
Density ( g/ cm3) 1.47 
Purity, min(%) 99 
  
 Two different silane-coupling agents were used for the surface modification of 
Hydroxyapatite particles. These agents were (3-aminopropyl) triethoxysilane (Fluka) 
and (3 Mercaptoprophy trimethoxysilane) (Merck). 
 Simulated body fluid (SBF) was prepared by dissolving reagent grade chemicals 
of NaCl, NaHCO3, KCl, Na2HPO4, MgCl2.6H2O, CaCl2.2H2O, and Na2SO4 in deionised 
water. The solution was buffered at physiological pH 7.4 and at 37 0C with 50 mM 
trishydroxymethyl aminomethane [( CH2OH)3CNH2] (THAM) and 36.23 mM HCl acid. 
Sodium Azid was also added into SBF for preventing microbial effects. 
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5.2. Methods  
 
Experimental methods can be summarised in six groups: 
 Size reduction of hydroxyapatite 
 Synthesis of hydroxyapatite 
 Surface treatment of hydroxyapatite 
 Preparation of Polylactide based composite films containing hydroxyapatite 
particles 
 Characterisation of hydroxyapatite 
 Characterisation of composite films 
 
5.2.1. Preparation of Hydroxyapatite Powders 
 
5.2.1.1. Size Reduction of Hydroxyapatite 
 
Particle size analysis of the HA was done in order to determine the average 
particle size. Although HA was purchased as nearly as 1 m particles, hydrophilic HA 
particles may form agglomerate in the presence of moisture causing an increase in the 
average particle size. Therefore, the HA powder was milled using Multifix Ball Mill 
under wet condition. Zirconia balls were used as grinding media during ball milling. 
HA powders were ground at a speed of 120 rpm for 8 h. diameters.  
Particles less than 1 m in size were separated according to Stoke’s Law in a 
hydroxyapatite-water suspension. Stoke’s Law [56] given by Equation 5.1, states that 
under fixed condition; the time taken for a particle to settle to a fixed depth is inversely 
proportional to the square root of its spherical 
 
V= l / t= a2 (Dp – Dl) g / 18                    (5.1) 
Where V: Velocity (cm/s) 
Dp: Particle Density (g/cm3) 
Dl: Liquid Density (g/cm3) 
g: Gravitational force (g.cm / s2) 
a: Particle diameter (cm) 
: Viscosity of liquid (cm3/g) 
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l: a distance (cm) 
t: time for particle to settle a distance (sec) 
Dp and Dl were taken as 3.16 g/cm3 and 1 g/cm3 respectively. The time required 
for 1m HA particles to settle down could be easily determined using equation 5.1. 
After sedimentation process, the suspension was taken separated from the solids 
settled at the bottom of the container. This suspension was washed by ethanol and used 
for obtaining soft powder. The slurry was dried in an oven at 120 0C for 8 h. 
 
5.2.1.2. Synthesis of Hydroxyapatite 
 
In this study, Hydroxyapatite was synthesised by precipitation technique. A 
batch mixture with Ca/P=1.67 molar ratio was prepared using starting materials Ca 
(NO3). 4 H2O and (NH4)2HPO4. Ca (NO3). 4 H2O aqueous solution of 1000 ml (3.78 wt 
%) was slowly dropped into stirred, 1000 ml (NH4)2HPO4 aqueous solution (1.3 wt %) 
for 150 min. The pH of both solutions was kept at around 10-11, with adjusting NH4 
OH addition and reaction was carried out at room temperature. Solution pH was held 
above 10 by adding ammonium hydroxide due to stability of HA. The precipitate of 
calcium hydroxyapatite was obtained according to the reaction given below; 
 
10 Ca(NO3).4 H2O + 6 (NH4)2HPO4 +8 NH4 OH  
Ca10 (PO4)6 (OH)2 + 20 NH4NO3 + 6 H2O 
 
The obtained suspension was heated and mixed for 24 h that was aging time. 
The precipitate was separated by filtration using Bihner’s funnel. The obtained filter 
cake was washed with deionised water until the ammonia smell disappeared. After 
washing deionised water, filter cake was washed with ethanol to obtain mild powder. 
The filter cake was dried in oven at 900C-100 0C and mixed regularly. Then the 
dried powder was calcined at 400 0C for 3 h. 
  
5.2.1.3. Surface Treatment of  Hydroxyapatite 
 
Surface modification of hydroxyapatite was carried out to decrease the 
hydrophilic nature of its surface and to make it more compatible with the Polylactide 
(PLA) and its copolymer. Agglomeration of hydroxyapatite particles can be avoided in 
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polylactide composites by surface modification of particles, and a homogeneous 
dispersion of particles in composites can be obtained. 
HA powder, which was synthesised in laboratory, was treated with two different 
silane coupling agents: (3-aminopropyl)triethoxysilane (AMPTES) and 3-
merkaptopropyltrimethoxysilane (MPTMS). Chemical structures of surface modifiers 
used are tabulated in Table 5.4 
 
Table 5.4.Chemical Structures of Surface Modifiers. 
Surface Modifier Chemical Formula Producer 
AMPTES NH2-CH2- CH2- CH2-Si-(O- CH2-CH3)3 Fluka 
MPTMS SH- CH2- CH2- CH2-Si-(O-CH3)3 Merck 
 
To ensure a uniform coverage of the HA surface, silane coupling agents were 
applied from an aqueous ethanol solution. HA powder was added to a solution of silane 
coupling agent (0.5, 1, and 2 wt %) in aqueous ethanol solution (90 v %). HA to 
solution ratio was taken as 1:2 on weight / volume basis. Mixing of silane ethanol 
solution carried out hydrolysis reaction. The slurry was stirred for 1 h by magnetic 
stirrer and then kept for 2 h at room temperature for treatment of the HA with 
hydrolysed solution to improve the stability of the coating. Then, the resulting slurry 
was dried at 100-120 0C to form silanol structure. The powder was then stored in 
desiccator until use. The sequence of surface treatment process of Hydroxyapatite 
powder with silane coupling agents is shown in Figure 5.1. Y denotes organofunctional 
group of silane coupling agent. 
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Figure 5.1. Surface Treatment Process of HA with Silane Coupling Agents 
 
5.2.2. Preparation of HA/PLA Composite Films 
    
The poly (L-Lactide) (PLA) and poly (L-Lactide-D,L-Lactide) and poly (L-
Lactide-D-Lactide) copolymers (PDLA) composites containing 10 to 50 wt % untreated 
and treated Hydroxyapatite were prepared by using solvent casting technique. In this 
technique, chloroform was used as a solvent to prepare polymer solution. 
 
 HA powder 
Mixing Process 
for 1 hr at Troom 
0.5, 1, 2 wt %  
silane coupling agent 
in 90 v % ethanol soln 
    HA (wt) / Silane soln.(v) = 1:2 
           Hydrolysis Reaction 
Treatment of HA with 
hydrolysed solution for 2h at 
Troom 
        Condensation Reaction 
Drying process in an oven for 
12 h at T=120 0C  
Hydrolysis Rxn; 
YSi(O-CH2-CH3) + 3 H2O 
Y(SiOH)3+3 C2H5OH 
Condensation Rxn; 
 Si-OH+Y(SiOH)3 
 SiO-SiY+H2O 
Modified HA 
With Silane Coupling Agents 
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In the process of the experimental study, two different methods were used to 
prepare composite films. In the first method, PLA or PDLA was weighed accurately in 
to a Pyrex jar and measured volume of chloroform was added to the Pyrex jar to make a 
solution with desired concentration. PLA/ solvent ratio and PDLA / solvent ratio were 
in the range of 5-10  % (w/v) and 3-7 % (w/v), respectively. The mixture was stirred at 
room temperature for 1-2 h to obtain a homogenous polymer solution. HA powder was 
added into the prepared solution to make a polymer HA mixture. The PLA or PDLA / 
solvent / HA mixture was stirred for 12 h on the magnetic stirrer until HA was totally 
dispersed in the solution. In the second method, HA powders were dispersed in 
chloroform in ultrasonic bath for 1 h. and then, PLA or PDLA were added to the 
solution. Mixing time and temperature conditions were the same in both methods. 
The resulting mixture was then poured on glass surface using film applicator. Figure 
5.3 indicates simple film applicator used in this study. It was dried overnight at room 
temperature, then finally dried under vacuum oven at 40 0C for 3 h. The dried films 
were gently removed from the glass surface. PLA or PDLA / HA composite films were 
stored in desiccator until they use. Flow sheet of the preparation of composite films is 
shown in Figures 5.2, 5.3, 5.4 and 5.5, respectively. 
  
 
 
Figure 5.2. Mixture of  PLA or PDLA –HA Composites on Magnetic Stirrer at Troom . 
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Figure 5.3. Simple Film Machine. 
 
 
 
Figure 5.4.Prepared PLA or PDLA- HA Composite Films. 
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Figure 5.5. Separation of PLA or PDLA Composite Films from the Glass Surface. 
 
5.2.3. Characterization of Hydroxyapatite Powders 
   
Hydroxyapatite powder was characterised by particle size analysis, Fourier 
Transform infrared spectroscopy (FTIR), thermal gravimetric analysis (TGA), scanning 
electron microscopy (SEM) and SEM-EDX. 
 
5.2.3.1. Particle Size Measurement of Hydroxyapatite 
 
Particle size measurement provides the determination of the size distribution of 
particles. Particle size analyses of untreated commercial and synthesised HA are 
measured in the range of 10-1m by Micromeritics X-ray Sedigraph 5100. 
 
5.2.5.2. FTIR Analysis of Hydroxyapatite 
 
FTIR analysis gives information about the chemical structure of Hydroxyapatite and 
the chemical reactions between silane coupling agents and hydroxyapatite. Untreated 
and treated hydroxyapatites with different silane coupling agents were analyzed by KBr 
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pellet technique. The pellets were prepared by pressing of 5 g hydroxyapatite samples 
with 0.2 g of KBr. IR spectra were taken in the range of 400-4000 cm-1 with a Shimadzu 
FTIR 8201 Model. 
 
5.2.3.3. TGA  Analysis of Hydroxyapatite 
 
TGA of hydroxyapatite was carried out using Shimadzu Thermal Gravimetric 
Analyzer (TGA-51) from room temperature to 500 0C at a heating rate of 10 0C/min. 
The analyses were performed in a dry nitrogen atmosphere. N2 flow rate was 40 ml/ min 
and kept constant through out the experiments. 
 
5.2.3.4. XRD Analysis of Hydroxyapatite 
 
 X-Ray Diffraction of HA powder was performed on to determine the crystalline 
phase(s) present in the powder. 
 
5.2.3.5. SEM and EDX of Hydroxyapatite 
 
Scanning Electron Microscopy (SEM) was used to determine the particle 
morphology of the HA powder by using Philips XL- 305 FEG, because SEM and EDX 
analysis allow one to obtain information about the micro structure and elemental 
composition of HA powder. Energy Dispersive X-Ray (EDX) detected Ca/P ratio of 
untreated and treated Hydroxyapatite.  
 
5.2.4. Characterization of Composite Films 
 
5.2.4.1. Mechanical Characterization of the Composites 
 
Tensile testing of polymer composites containing (10, 20, 30, 40,wt %) untreated 
and treated hydroxyapatite were performed on a Testometric Universal Testing 
Machine. Load cell was 5 kgf, crosshead speed at 10 mm/min and the gauge length was 
50 mm. Tensile tests were applied at room temperature. Tensile test specimens were 
prepared as strips of 10-mm width according to ASTM D-882. At least three specimens 
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were tested for each composite film, the mean values were reported on the basis of the 
three specimens. 
 
5.2.4.2. Microstructural Characterization of HA/PLA Composites 
 
Optical micrographs of the composites with different surface modifiers, HA loading 
and polymer type were taken using transmission mode with a camera fitted to Olympus 
BX-60 microscope at 20X magnification. 
SEM analysis in composites allows one to obtain information about the micro 
structure and interaction between filler and matrix of a composite. Surface microscopy 
of the composites loaded with untreated and treated HA and fracture surface 
microscopy of tensile tested composites were observed with Philips XL-30S FEG 
scanning electron microscope (SEM). The samples were gold coated before use. The in 
vitro microstructural changes of the composites were also analyzed by means of SEM  
 
5.2.4.3. TGA Analysis of Composites 
 
Thermal analyses of pure PLA1 and PDLA1 films and their composites loaded 
with untreated HA were done using Shimadzu Thermal Gravimetric Analyzer 
(TGA,51). The experiments were carried out from room temperature up to 500 0C at 
heating rates 5, 10, 20 0C/min in order to determine the thermal degradation kinetics. 
The analyses were performed in a dry nitrogen atmosphere. N2 flow rate was 40-ml/ 
min and kept constant throughout the experiments.  
 
5.2.4.4. FTIR Analysis of Composites 
 
The IR Spectrums of the composite films were taken by placing the samples on 
the way of the beam using the transmission technique. IR Spectroscopy was used to 
identify molecules and the types of bonds inside the polymer composite structure, the 
presence of possible solvents. All the samples spectra were taken between 400 cm-1 to 
4400 cm-1 with a Shimadzu FTIR 8201 Model. 
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5.2.5. Hydrolytic Degradation of PLA, PDLA and Their HA Composites 
 
Weight loss and water absorption during storage at 37 0C in simulated body fluid 
(pH 7.4) were determined for all pure polymer films (PLA1, PLA2, PDLA1, PDLA2) and 
two different polymer (PLA1 and PDLA1) composites loaded with untreated HA (10, 
20,30,50 wt %). The effect of surface treatment on HA was also investigated on the 
water absorption and weight loss of the composites. The samples, which were nearly 
80-100 mg, were immersed into a glass bottle containing 25 ml SBF. The bottles were 
allowed to stand in a thermo-stated oven for predetermined periods of time. After being 
incubated for various period of time, the specimens were removed from the fluid and 
rinsed with distilled water. After wiping, the specimens were weighed and dried at room 
temperature for 3 h and then dried at 37 0C until the weight is constant. Each data point 
is the mean of two measurements. The pH of sample fluid was also monitored by 
Metrohm pH-meter as a function of time. Experimental set up for the biodegradation 
studies in simulated body fluid was shown in Figure 5.6. 
 
 
 
Figure 5.6. Experimental Set-up for the Biodegradation of the Films in Simulated Body 
Fluid. 
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5.2.5.1 Preparation of Simulated Body Fluid (SBF) 
 
Simulated body fluid was prepared according to procedure in the literature [18] 
by dissolving reagent grade chemicals of NaCl, NaHCO3, KCl, Na2HPO4, MgCl2.6H2O, 
CaCl2.2H2O, and Na2SO4 in deionised water and they were added to the solution in the 
order they are listed. The simulated body fluid solution was buffered at physiological 
pH 7.4 and at 37 0C with 50 mM trishydroxymethyl aminomethane [(CH2OH)3CNH2] 
(THAM) and 36.23 mM HCl acid. HCl was added before calcium chloride and THAM 
was the last reagent added to the solution. And also Sodium Azid (4 g) was added into 
SBF for preventing microbial effects. The amounts of reagent grade chemicals were 
listed in Table 5.5. 
 
Table 5.5. Reagents Used  for the Preparation of SBF (pH 7.4, 2 L) 
Order Reagent Amount 
1 NaCl 13.094 g 
2 NaHCO3 4.5360 g 
3 KCl 0.7440 g 
4 Na2HPO4 0.2480 g 
5 MgCl2.6H2O 0.6100 g 
6 1 M HCl Nearly 80 ml 
7 CaCl2.2H2O 0.7360 g 
8 Na2SO4 0.1420 g 
9 trishydroxymethyl 
aminomethane 
12.114 g 
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Chapter 6 
 
 
RESULTS AND DISCUSSION 
 
 In this study, the preparation and characterization of hydroxyapatite-polylactide 
composite films for biomedical applications were investigated. Poly(L-Lactide) and 
Poly(D-Lactide-L-Lactide) copolymer were used as a polymer matrix and HA was used 
as a filler for the preparation of the composites. Surface treatment of the filler was 
carried out with two different silane coupling agents: 3-aminopropyltriethoxysilane 
(AMPTES) and 3-mercaptopropyltrimethoxysilane (MPTMS) to improve dispersion of 
particles in the matrix and adhesion between polymer and filler. In the scope of this 
study, the effects of a number of parameters such as type of polymers, hydroxyapatite 
(HA) type, HA loading, surface modification of HA and its concentration on the 
mechanical, micro structural, thermal and hydrolytic degradation properties of the 
composite films have been investigated and reported. 
 
6.1. Characterization of Hydroxyapatite Powder 
 
 Commercial HA and synthesized HA, which were untreated and treated, were 
characterized using different methods to examine particle size distribution, crystal 
phases, the chemical structure and the chemical reactions between silane coupling 
agents and HA, microstructure and Ca/P ratio of HA. 
 
6.1.1. Particle Size Measurement of HA 
 
 Particle size measurement provides the determination of the size distribution of 
particles. Although the particles size of the commercial HA (HA1) is nearly 10 m, very 
hydrophilic HA particles may form agglomerates in the presence of moisture causing an 
increase in the average particle size. Therefore, commercial HA was ground. After size 
reduction process of HA, milled HA (HA2) was obtained with an average particle 
diameter nearly as 3 m. The average particle size of hydroxyapatite which was 
synthesized by precipitation technique was found as 0.28 m.  The particle size 
distributions of commercial HA powder (HA1), milled HA powder (HA2), and 
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synthesized HA powder (HA3) were given in Table 6.1. The most fine particle size was 
obtained for the synthesized HA, (HA3) as seen in Table 6.1. 
 
Table 6.1. The Particle Size Distribution of Commercial HA Powder (HA1), Milled HA 
Powder (HA2), and Synthesis HA Powder (HA3). 
HA1 HA2 HA3 
Low 
Diameter 
Cumulative 
Mass % 
Low 
Diameter 
Cumulative 
Mass % 
Low 
Diameter 
Cumulative 
Mass % 
10.00 81.7 10.00 87.3 5.000 99.6 
5.000 69.1 5.000 76.5 2.000 95.1 
2.000 46.9 2.000 63.2 1.500 91.4 
1.500 40.8 1.500 59.5 1.000 85.3 
1.000 43.5 1.000 54.4 0.500 73.5 
0.500 27.0 0.500 47.0 0.100 54.6 
 
6.1.2. FTIR Analysis of HA 
 
 The FTIR spectra of untreated HA powder in Figure 6.1 shows that the 
stretching and vibration band of OH- appear at about 3572 cm-1 and 572-632 cm-1 
respectively.  Phosphate peaks can be seen at 1408, 1091, 603 and 571 cm-1 [57,58]. 
The IR spectrum at 1620 cm-1 represents the H2O bending. As a result, FTIR spectra 
determined in this work matches with those reported previously in the literature for the 
HA powder. Figure 6.1 also shows the comparison of FTIR spectra of HA powder 
treated with 1 wt % aminofunctional silane (silane1) and mercaptosilane (silane 2). The 
silane deformation and siloxanes (Si-O-Si) bond formed as a result of reaction between 
HA and silane coupling agents absorbs at 1030 and 1130-1000 cm-1, respectively. These 
characteristics group indicating the reaction between the silane and HA were not 
observed in the silane treated HA. This may be due to presence of the strong vibration 
of HA in the range of 1200-900 cm-1 and also amount of silane concentration used on 
HA modification. 
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Figure 6.1. FTIR Spectra of Untreated Hydroxyapatite, Treated HA with Silane 1 and 
Silane  2. 
 
6.1.3. X-Ray Diffractometry (XRD) of HA 
 
The phase composition and structure of the synthesized HA powder was 
characterised by XRD. X-ray diffraction provides information about the crystal 
thickness in mats of single crystals. Wide-angle X-ray diffraction can be used to 
determine the crystal size. Small crystals give broad Braggs reflections and a simple 
way of assessing the crystal thickness (Dhkl) perpendicular to a given set of (hkl) planes 
is through the Scherrer equation [59]. 
 
   Dhkl= K /  Cos         (6.1) 
where; 
K : the Scherrer shape factor 
 : the wavelength of the x-ray 
 : the breadth of the diffraction peak associated with the hkl planes. 
      Untreated Hydroxyapatite 
      Treated HA with Silane 1 
      Treated HA with Silane 2 
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 Figure 6.2 illustrates XRD patterns of synthesized HA powders. The result 
showed that XRD pattern of synthesized powder HA obtained in these work matches 
with these reported previously in the literature [60]. Crystallographic particle size of HA 
that was determined by using Equation (6.1) was found as 27 nm. 
 
Figure 6.2.The X-ray Diffraction Pattern of HA Powder 
 
6.1.4. Microstructural Properties of HA 
 
Figure 6.3 (a) and (b) show SEM micrographs of untreated and treated HA with 
1 wt % aminofunctional silane coupling agent, respectively. As shown in Figure 6.3(b), 
the surface modification of HA with silane coupling agent reduces the agglomerate size 
of HA particles significantly.  
Figure 6.4(a) and (b) illustrate EDX analysis results of the untreated and treated 
HA with 1 wt % aminofunctional silane. Ca/P ratio of the untreated HA powders was 
determined by SEM-EDX analysis and found as approximately 1.6. EDX studies 
showed that the major surface components of untreated HA surface were Ca, P and O. 
As seen in Figure 6.4 (b), Si and N atoms were observed in the spectra of treated HA 
powders which indicated the presence of silane coating on HA. 
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(a) 
 
 
 
(b) 
Figure 6.3 SEM Micrographs of Hydroxyapatite Prepared by Precipitation Technique. 
(a) Untreated HA (b) Treated HA with Silane Coupling Agents.  
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(a) 
 
(b) 
Figure 6.4 EDX spectra of the untreated and treated HA with aminofunctional silane 
coupling agent. 
 
6.2. Characterization of HA/ PLA Composite 
  
 The PLA-Hydroxyapatite composite films were prepared by solvent casting 
techniques. In the initial stages of the work, the optimum polymer/solvent ratio for all 
polymers studied were determined. Chloroform was used as a solvent in all polymer-
solvent solution procedure. The visual observations on the properties of the four 
different films were given in Tables 6.2-6.5, for PLA1, PDLA1, PLA2, and PDLA2, 
respectively. During preparation of polymer –solvent solution, other process variables 
were kept constant. The optimum polymer /solvent ratio for each polymer was 
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determined and found as 0.1, 0.05, 0.05 and 0.04 for PLA1, PDLA1, PLA2, and PDLA2, 
respectively and fixed for the rest of this work. 
 
Table 6.2. Effect of Polymer/ Solvent Ratio for PLA1/Chloroform System 
PLA-1/Chloroform (g/cc) Final Structure 
0.07 Nonuniform and thin thickness, 
0.1 Uniform thickness 
0.12 Highly viscous paste 
 
 
Table 6.3. Effect of Polymer/ Solvent Ratio for PDLA1/Chloroform System 
PDLA-1/Chloroform (g/cc) Final Structure 
0.07 Highly viscous paste 
0.05 Uniform thickness 
0.03 Nonuniform and thin thickness, 
 
Table 6.4. Effect of Polymer/ Solvent Ratio for PLA2/Chloroform System 
PLA-2/Chloroform (g/cc) Final Structure 
0.07 Highly viscous paste 
0.05 Uniform thickness 
0.03 Nonuniform and thin thickness, 
 
Table 6.5. Effect of Polymer/ Solvent Ratio for PDLA2/Chloroform System 
PDLA-2/Chloroform (g/cc) Final Structure 
0.05 Highly viscous paste difficult solving 
0.04 Uniform  thickness, 
0.03 Very thin, Uniform thickness 
 
 In the preparation of polylactide-hydroxyapatite composites by the solvent 
technique, two different preparation methods were carried out. In the first method, 
firstly, polymer-solvent mixture is prepared and then, HA is added (PLA or PDLA + 
solvent + HA). Second method follows firstly the dispersion of HA in the solvent, and 
then polymer is added (HA + solvent + polymer) PLA-HA composites prepared by 
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second method gave more homogeneous dispersion of HA in polymer matrix than those 
prepared method by first method. 
 
6.2.1. Mechanical Testing of HA/PLA Composites 
 
  Tensile tests of Poly(L-Lactide) and Poly (D-Lactide-L-Lactide) copolymer 
composites filled (10, 20, 30, and 50 wt %) with the untreated and treated 
hydroxyapatite were conducted to determine how mechanical properties were 
influenced by the particle size of  HA, the presence of surface modifiers (AMPTES and 
MPTMS) and their concentrations, polymer types and HA loading. Experimental tensile 
test results of these samples were given in Table A.1 in the Appendix. Young’s 
Modulus, yields stress, tensile fracture stress and fracture strain values of the 
PolyLactide composites as a function of HA were measured. 
 The effects of polymer type, preparation method, HA loading, surface treatment 
of HA on the Young’s modulus of the Polylactide-HA composites were studied and 
shown in Figures 6.5-6.12. 
Figure 6.5 indicates modulus of elasticity of different PolyLactide polymers used 
in this study. As expected and seen in the Figure 6.5, since poly-L-Lactide polymers, 
PLA1 and PLA2 are semicrystalline polymers, their modulus should be higher than Poly 
L- Lactide-D Lactide copolymers (PDLA1 and PDLA2) which have amorphous 
structure. Elastic Modulus of PLA1 was found to be the highest among all. Among the 
PDLA1 polymers, PDLA2 has higher elastic modulus. 
Figure 6.6 shows the Young Modulus of PLA1 composites containing 10 wt % 
HA which were prepared by two different methods. Young Modulus of composites that 
was prepared by the second method was greater than those prepared by the first method. 
This is due to fact that the better dispersion of HA in polymer matrix and less 
agglomeration of the HA particles in the polymer matrix were obtained. Since the 
homogeneous dispersion plays an important role in improvement of the mechanical 
properties, the better mechanical properties were obtained for the composites prepared 
by second method. Table 6.6 shows the mechanical properties of the PLA-HA 
composite containing 10 wt % HA prepared by both first and second methods. 
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Figure 6.5 The Young’s Modulus of Polymers  
   
Figure 6.6 Effect of Preparation Methods on Young Modulus Value of the 10 wt % HA 
Loaded PLA1 Composites. 
 
Table 6.6. The Comparison of the Mechanical Properties of the 10 wt % Loaded PLA1 
Composites Prepared by two Different Preparation Methods. 
 
Mechanical Properties First Method Second Method 
Young’s Modulus, MPa 565.8 644.4 
Yield Stress, MPa 23.1 28.1 
Stress at break, % 4.7 5.1 
Elongation at break, mm 3.2 3.7 
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The effect of particle size of hydroxyapatite powder on the mechanical 
properties of the PLA1 composites containing 10 wt % HA particles were investigated 
and shown in Table 6.7. As shown in Table 6.7, Young’s Modulus and yield stress 
increased as the particle size of HA reduced. On the other hand, stress at break and 
elongation at break values decreased with decreasing particle size. 
 
Table 6.7 Effect of Particle Size of Hydroxyapatite on Mechanical Properties of PLA1 
Composites 
Mechanical Properties HA1/PLA1 HA2/PLA1 HA3/PLA1 
Young’s Modulus, MPa 644.2 676.5 877.7 
Yield Stress, MPa 28.14 30.9 39.2 
Stress at break, % 5.10 4.8 4.8 
Elongation at break, mm 3.7 3.9 3.4 
 
Figure 6.7 shows typical stress-strain curve of the PLA1 composite containing 10 
wt % HA obtained from Tensile Test Machine, as described above. The slope of the 
initial linear part of the curve gives the “Young’s Modulus”. The maximum stress 
values (indicated with bars) are defined as the “yield point”. These values for the 
composites were measured and given in Appendix 1-A. 
The effects of HA content and polymer type on Young Modulus (Elastic 
Modulus) of PLA-HA composites were studied and shown in Figure 6.8. Young’s 
Modulus clearly had a positive correlation with the mixing ratio of composites. Thus, 
Young’s Modulus of the composites depends on the loading of HA. It was observed that 
Young’s Modulus of the composites increased as HA content increases. Up to 40 wt % 
HA loading for both polymer types then, started to decrease. This could be due to the 
increase in agglomeration size of the HA particles in the polymer matrix which could 
cause the weak adhesion between polymer and filler. 
 In addition to this, it was decided by the composite effect of Young Modulus of 
both HA and polymer type. Young Modulus of PLA1 and its composites are found to be 
significantly higher than that of PDLA1. This is again due to the fact that PLA is a semi 
crystalline polymer and its mechanical strength should be higher compared to the 
amorphous PDLA polymer as expected. 
 
 
 72
 
 
 
 
Figure 6.7 Typical Stress-Strain Curves of the PLA1 Composite Containing 10 wt % 
Untreated HA. 
 
Figure 6.8 Young’s Modulus of PLA1/HA3 and PDLA1/HA3 Composites with Respect 
to HA3 Content.   
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The effect of surface treatment of the HA filler on Young’s Modulus of the 
composites was investigated. Figure 6.9 and 6.10 show the influence of the surface 
modifier concentration of silane coupling agents on Young’s modulus of composites 
containing 20-wt% hydroxyapatite for PLA1 and PDLA1, respectively. Young’s moduli 
of composites were measured for three different types of silane concentration, which 
was 0.5, 1, and 2 wt %. As seen in the figures, silane treatment leads to increase in 
Young Modulus due to the improvement of adhesion between polymer and filler and 
dispersion of filler in the polymer matrix. Although 1 wt % AMPTES (Silane1) 
coupling agent concentration shows maximum on Young Modulus of the PLA 
composites, 0.5 wt % MPTMS (Silane2) coupling agent concentration shows a 
maximum for the PDLA composites as seen in Figures 6.9 and 6.10. For both 
composites, Young Modulus decreases with increasing silane concentration after the 
maximum point. The maximum Young’s Modulus values for 1 wt % silane1 coupling 
agent concentration show the maximum strength of interaction between polylactide and 
hydroxyapatite. Therefore, 1 wt % silane1 concentration was choosen for PLA 
composites. On the other hand, the maximum Young’s Modulus values for PDLA 
composites were seen at 0.5-wt % silane2 coupling agent concentration. The PDLA 
composite modified with silane 2 is always stiffer than the one containing untreated HA 
and modified with silane1. For this reason, surface modification of HA was done 1 wt 
% silane 1 concentration, and 0.5 wt % silane 2 concentration for PLA and PDLA 
composites, respectively.  
Figure 6.9 Effect of Silane Coupling Agents Concentration on the Young’s Modulus of 
PLA1 Composites Containing 20 wt % HA.  
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Figure 6.10 Effect of Silane Coupling Agents Concentration on the Young’s Modulus of 
PDLA2 Composites Containing 20 wt % HA.  
  
 Deng et al [35] studied the preparation and mechanical properties of 
nanocomposites of Poly (D,L-Lactide) with Ca-deficient HA nanocrystals which were 
prepared by solvent casting technique using dimethylformamide. The obtained 
nanocomposites are semitransparent films with the thickness about 0.1 mm. The 
relationship between the HA particles loading and tensile modulus for HA/ PLA 
composites has been investigated in their study. For the composite containing 10.5 v % 
HA, the modulus even reaches to 2.47 GPa as compared to 1.66 GPa for pure PLA. 
Tensile modulus for composite increases with HA loading. Yield stress for the 
composites varies irregularly with HA loading. In the other study, the preparation and 
characterization of HA / PolyL-Lactide composites were examined by Shikinami and 
coworkers [25]. The composites were prepared by forging process.  Uncalcined and 
unsintered HA (u-HA) were used as filler in their study. Effect of u-HA loading on the 
mechanical properties of u-HA / PLA was investigated. The gradual increase in tensile 
modulus was proportional to the fraction of HA particles. 
Figure 6.11 and 6.12 show modulus of elasticity of PLA composites containing 
untreated and treated HA with 1 % AMPTES and PDLA composites containing 
untreated and treated HA with 0.5 % MPTMS, respectively. The modulus of composites 
increased with increasing untreated and treated HA content up to 30-wt % and then 
decreased. This may be due to the increase in the agglomeration size with an increase in 
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HA loading which could cause poor adhesion between polymer and HA. The adhesion 
between polymer-filler plays an important role in the improvement of mechanical 
properties. As seen in these Figures, Young’s Modulus values of all PLA and PDLA 
composites loaded with treated HA were greater than those loaded with untreated ones. 
This result indicated that the better dispersion HA into polymer matrix and interfacial 
enhancement between hydroxyapatite and poly-L-Lactide or poly D,L-Lactide matrix 
were achieved by the treatment of HA with silane coupling agents.  
According to the other mechanical test results given in Appendix 1A, two 
important points can be discussed. Yield stress of the composite decrease with an 
increase in HA content for both polymer types.  The percent elongation becomes much 
smaller than in the composites with higher HA contents as expected. PDLA copolymer 
and its composites are relatively softer, weaker, and much more flexible compared to 
the PLA homopolymer and its composites.   
 
 
Figure 6.11 Effect of Coupling Agents on Young Modulus of PLA Composites with 
Respect to HA Contents. 
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Figure 6.12 Effect of Coupling Agents of Young Modulus of PDLA Composites with 
Respect to HA Contents.  
 
 
6.2.2. Microstructure Analyses 
 
The effect of preparation methods on microstructural properties of PLA 
composites containing 10 wt % HA was examined by their optical micrographs.  In the 
second method, HA was dispersed in chloroform using ultrasonics for 45 min prior to 
PLA dissolved. Optical micrographs of PLA composites prepared by first method and 
second method for 10 wt% untreated as-received commercial HA composites are shown 
in the Figures 6.13 and 6.14, respectively. As seen in these figures, HA is better-
dispersed in PLA composite, which were prepared by second method, compared to the 
composites prepared by first method. Although there are still agglomeration of HA 
particles in PLA matrix in Figure 6.13, the sizes of the agglomerations are much lower.  
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Figure 6.13. Optical Micrographs of PLA-HA Composite (First preparation 
method)(20X)  
 
 
 
Figure 6.14. Optical Micrographs of PLA-HA Composite (2nd preparation 
method)(20X)  
10 m 
10 m 
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The effect of the surface modifier concentration of silane coupling agents for 
different polymers (PLA, PDLA) on surface structure of composites containing 20-wt% 
hydroxyapatite was examined by the optical micrographs. Figure 6.15 shows the optical 
micrographs of PLA composites containing treated HA with 0.5, 1 and 2 wt % 
AMPTES. As seen in the Figure 6.15 (b), 1 wt % AMPTES treated HA shows more 
homogeneous dispersion of HA particles in the PLA matrix. Since good dispersion of 
filler in the matrix is required in order to obtain composites having satisfactory 
mechanical properties, 1 wt % AMPTES was selected as optimum silane coupling agent 
concentration for PLA matrix composites. 
The optical micrographs of PLA composites consist of treated hydroxyapatite 
with 0.5, 1, 2 wt % MPTMS are illustrated in Figure 6.16. As seen in the figure, as a 
result of agglomeration and voids, non-homogeneous distribution of treated HA 
particles in the PLA matrix. The morphology of these composites was compared to 
those of corresponding the PLA composite containing treated HA with 0.5, 1, 2 wt % 
AMPTES. Mechanical and microstructural properties of PLA composite containing 
treated HA with 1 wt % AMPTES gave the mechanical results. Therefore, 1 wt % 
AMPTES was choosen as optimum silane coupling agent concentration for PLA 
composites. 
The effect of the surface modifier concentration of silane coupling agents for 
PDLA on surface structure of composites containing 20-wt% hydroxyapatite was also 
examined by the optical micrographs. Merkapto silane coupling agent was used for the 
modification HA in the PDLA composite because treated HA with 0.5 wt % MPTMS 
gave the better dispersion of HA in the PDLA matrix, as well as better good mechanical 
properties. Figure 6.17 shows optical micrograph of PDLA composite containing 20 wt 
% modified HA with 0.5 wt % MPTMS. 
The effect of particle size of HA on the microstructural properties was also 
studied. Figure 6.18 indicates the SEM images of PLA composites containing 10 wt % 
untreated HA prepared by using three different particle size of HA. Larger HA particles 
affect appearance of deformation of the polymer composites. On the other hand, 
aggregation tendency of small particles is higher than that of large particles. As shown 
in the Figure 6.18 (c), the dispersion of HA in the polymer matrix is much better in PLA 
composites containing smallest particle size of HA. 
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(b) 
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(c) 
 
Figure 6.15 Optical Micrographs of PLA Composites Containing 20 wt %  Treated HA 
with (a)0.5 wt % AMPTES/HA, (b)1 wt % AMPTES/HA, (c) 2 wt % AMPTES/HA 
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(b) 
 
 
( c ) 
 
Figure 6.16 Optical Micrographs of PLA Composites Containing 20 wt %  Treated HA 
with  (a) 0.5 wt % MPTMS/HA, (b) 1wt% MPTMS/HA, (c) 2 wt % MPTMS/HA 
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Figure 6.17 Optical Micrograph of PDLA Composites Containing Treated HA with 
MPTMS. 
 
SEM micrographs of tensile fracture surfaces for PLA composites with two 
different particle size of HA are shown in Figure 6.19. As seen in the Figure 6.19(b), 
although the agglomerate size of synthesized HA (HA3) in the PLA matrix was higher 
than that of the commercial HA (HA1), better dispersion of HA in PLA matrix was 
obtained by using the synthesised HA. 
Particularly, good dispersion of HA particles in the polymer matrix is required in order 
to obtain the composites having satisfactory mechanical properties. Figure 6.20 shows 
the SEM micrographs of PLA composites loaded 20 wt % untreated and treated HA 
with 1 wt % AMPTES. The agglomerate size of the treated HA with amino functional 
silane coupling agents in the matrix was found to be lower than that of the untreated 
HA. This showed that silane coupling agent improved the dispersion of HA in the 
polymer matrix. 
 
10 m 
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(a) 
 
             
(b) 
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          ( c ) 
 
Figure 6.18 SEM images of  PLA Composites Prepared by Using Three Different 
Particle Size of HA (a) HA1/PLA Composite (b) HA2/PLA Composite (c) HA3/PLA 
Composite. 
  
SEM was also used to examine the effects of the surface treatment of HA 
powder on the interface between polymer and HA, and HA loading on the 
microstructural properties of the composites. Figure 6.21 shows SEM images of surface 
of the composites containing 10, 20, and 30 wt % treated HA with 1 wt % AMPTES. 
SEM showed more homogeneous distribution of treated HA particles in the polymer 
matrix compared to the untreated HA particles, which had a maximum 10 m 
agglomeration size in the polymer matrix. However, as the HA weight percentage of 
HA in the polymer was increased from 10 to 30 wt %, the agglomeration size of treated 
HA particles was slightly increased. Although it is shown that more homogeneous 
distribution of HA with silane treatment HAs1 at microscopic level was observed, 
agglomeration increased with an increase in HA loading.  
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(a) 
 
              
(b) 
 
Figure 6.19 SEM Micrographs of Tensile Fracture Surfaces of PLA Composites 
Prepared by Two Different Particles Size of HA (a) HA1/PLA Composite (b) HA3/PLA 
Composite 
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(a) 
 
             
(b) 
 
Figure 6.20 SEM micrographs of 20 wt % PLA composites consist of untreated and 
treated HA with 1 wt % AMPTES. 
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( a ) 
 
                
              ( b ) 
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     ( c ) 
 
Figure 6.21 PLA Composite Films Containing (a) 10 %, (b) 20 %, (c) 30 % wt treated 
HA with amino functional silane coupling agent. 
  
The effect of surface treatment on the interface between PLA matrix and HA 
powder was investigated by examining the fracture surface of tensile tested composites 
with SEM.  Figure 6.22 and 6.23 show SEM micrographs of the fracture surfaces of 
PLA composites containing 10 wt % unmodified and modified HA with 1 wt % amino 
functional silane coupling agent at two different magnifications, respectively. Although 
the adhesion between polymer and HA was not bad in Figure 6.22, the agglomeration 
size of HA particles was higher than that of treated HA particles. 
As seen from the Figure 6.23, the treatment of HA with silane coupling agent 
improved the dispersion of HA particles in to the matrix and the reduced agglomeration 
size. The micrograph on the Figure 6.23 shows that the enhanced modification of 
AMPTES treated composite interface compared to untreated one. HA particles are not 
seen very clearly due to covering of HA particles by polymer matrix. This indicates 
wetting of HA particles with the matrix due to improvement of adhesion and dispersion. 
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          (a) 
 
 
           (b) 
 
Figure 6.22. SEM Micrographs of Fracture Surfaces of the PLA1 Composites Loaded 
with 10 wt % Untreated HA 
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(a) 
 
              
(b) 
      
Figure 6.23. SEM Micrographs of Fracture Faces of the PLA1 Composites with Treated 
HA. 
 
 91
 
Figure 6.24 showed the SEM micrographs of the poly-L-Lactide (PLA1) 
composites containing 40 wt % treated HA with 1 wt % AMPTES silane coupling 
agent. As seen in Figure 6.24, PLA composites containing 40 wt % HA do not show 
adhesion. Poor interfacial adhesion was obtained for the 40 wt % HA containing 
composites. Void was present between filler and polymer. That’s why the mechanical 
properties of the composites were weakened. 
Figure 6.25 indicates the SEM micrographs of PDLA composites loaded with 10 
wt % modified HA with 0.5 wt % MPTMS at different magnification. As seen from the 
figure, modification of HA with silane coupling agent does not sufficiently improve the 
interface between HA and PDLA and poor interfacial adhesion between two phases was 
clearly seen. This explains why the Young’s Modulus of the 40 wt % HA loaded 
composites had a lower value than 30 wt % HA loaded composites. 
 
 
 
 
Figure 6.24 SEM Micrographs of the poly-L-Lactide (PLA1) Composites Containing 
40 wt % Treated HA with 1 wt % AMPTES Silane Coupling Agent. 
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(a) 
 
                 
 
               (b) 
Figure 6.25 SEM Micrographs of PDLA Composites Prepared by 10 % Modified 
HA with 0.5 wt % MPTMS for Different Magnification. 
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6.2.3. Results of Thermal Analyses 
 
 In this study, TGA and DSC were used for the thermal characterization of the 
PLA and PDLA and their composite films consist of HA. The melting, glass transition 
and degradation temps of the polymers were studied by DSC. TGA was used to 
determine the thermal degradation behaviour of polylactide-HA composites as well as 
HA content in the composites.  
Figures 6.26 shows the DSC curve of PLA polymer at a heating rate of 10 
0C/min in a stream of dry nitrogen gas. As seen from DSC curve in the Figure 6.26, the 
glass transition, melting, and the degradation temperatures of the PLA, were found to 
be 178.8 0C, and 366.8 0C, respectively. The heat of fusion of the sample came out to 
be 42.28 kj/kg. The energy of the second endothermic that was attributed to 
degradation of PLA was found as 671.4 kj/kg.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.26.  DSC curves of Poly-L-Lactide. 
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Figure 6.27 shows the TGA curves of PLA1 and PDLA1 analysed with a heating 
rate 10 0C/min in a nitrogen atmosphere. The weight loss started at around 220 0C and 
at terminates about 380-400 0C. The mass loss occurs in two steps. The first and the 
sharp decrease in the mass occurred at between 220-380 0C. The second and the slow 
mass loss step was observed around 380-480 0C. As seen in the figure, there is not 
much difference obtained between thermal degradation curves of PLA and PDLA 
polymers. 
 
Figure 6.27. TGA curves of PLA and PDLA 
   
Figure 6.28 shows the effect of heating rate on the degradation of Poly-DL-
Lactide composite containing 10 % untreated HA. With increase in heating rate, 
while the thermograms shifted towards the right, the onset of degradation 
temperature increased and also termination of degradation temperatures increased. 
That is, the onset of degradation, and the termination of degradation values for 
heating rates of 5, 10, and 20 0C/min were about 300 0C, 325 0C, 345 0C, and 385 0C, 
390 0C, 410 0C, respectively. 
 The Poly (L-Lactide) (PLA) and its composites loaded with 20 wt %-50 wt % 
untreated HA prepared by the second method were analyzed by TGA with a heating 
rate of 10 0C/min. Figure 6.29 shows the TGA curves of these composite samples. As 
shown on the TGA curve, weight loss of PLA increased rapidly above 270 0C and 
weight losses of all composite samples increased nearly above 310 0C. Samples 
containing 20 and 30 wt % untreated HA behaved similar to each other. Their onset 
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and termination of degradation temperatures were very close each other as indicated 
in Figure 6.29. As shown in figure, with the increase HA loading, the onset of 
degradation temperatures of composite shifted towards left, but termination 
degradation temperature shifted towards the right and degradation was slow down. 
This indicates that the addition of HA into polymer matrix slowed down thermal 
degradation of the polylactide polymers. 
Figure 6.28. Effect of heating rate on the degradation behaviour of PDLA composites 
containing 10 wt % HA. 
 
The kinetic analysis was performed at heating rates of 5, 10 and 20 0C/min 
for the PLA and PDLA and their composite samples. Kinetic analyses of these 
samples were done with in a temperature range 300-420 C for fast mass loss step  
using Shimadzu 51 TGA kinetic analysis software according to the Ozawa methods. 
Equation  used for the analysis of the experiments was given below; 
 
ln (d/dt)x[1 /(1-)]n = ln (A/)-E/RT                      (6.1) 
  
where:  : rxn rate  
A: frequency factor; 
E: Activation Energy;  
: Heating rate;  
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t: time;  
T: temperature;  
 r: rxn order  
The Ozawa plot shows the logarithm of heating rate versus 1/T at constant x 
values (reaction percent) for different conversions (weight losses). From the slope of 
the lines, the activation energy, E, is calculated for different weight losses and the 
averaged by the software. Reaction rate constant for the degradation reaction was 
determined using Arrhenius equation given below at 300 0C. 
 
k= A e-E/RT                                                          (6.2) 
The kinetic analysis results of the samples were shown in Table 6.9. The kinetic 
energies and related parameters obtained for all samples were given in the Table. As 
seen in Table 6.8, both activation energy and reaction rate constant decrease with 
increasing HA loading. This showed that thermal decomposition rate slows down with 
the addition of HA in PLA1 and PDLA1 matrix. 
 
Figure 6.29 TGA curves of PLA and PLA composites 
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Table 6.8. Kinetic Analysis Results of Poly(L-Lactide), Poly(D,L-Lactide) and Their 
Composites 
 
Samples 
HA 
Content 
( %) 
Activation 
Energy 
E (kj/mol) 
Frequency 
Factor 
A (min-1 ) 
k @ 300 0C 
(min-1) 
Poly (L-Lactide) 0 184.1 2.96 x 1014 2.85 x 1014 
Poly (L-Lactide) 10 157.1 3.12 x 1012 3.02 x 1012
Poly (L-Lactide) 20 139.6 5.38 x 1010 5.22 x 1010 
Poly (L-Lactide) 30 132.6 1.70 x 1010 1.65 x 1010 
Poly (L-Lactide) 50 132.5 6.80 x 1010 6.61 x 1010 
Poly (D,L-Lactide) 0 104.6 1.05 x 108 1.03 x 108 
Poly (D,L-Lactide) 10 171.5 5.30 x 1013 5.11 x 1013 
Poly (D,L-Lactide) 20 145.1 3.94 x 1011 3.82 x 1011 
Poly (D,L-Lactide) 30 156.8 1.70 x 1012 1.64 x 1012 
Poly (D,L-Lactide) 50 124.5 4.38 x 109 4.26 x 109 
 
 
6.2.4. FTIR Spectroscopy Results 
 
Infrared (IR) as well as Fourier transform infrared (FTIR) spectroscopy has been 
widely used as powerful methods in characterization of biomedical materials.  FTIR 
spectroscopy was used to investigate the chemical composition of the poly-L-Lactide 
and poly-D,L-Lactide and their composites loaded with untreated and treated HA films. 
Film samples were used for the analysis of the polymer and composite. The spectral 
range of 400-4000 cm-1 was used. 
The FTIR Spectra of PLA and PDLA that are used throughout this study are 
given in Figures 6.30 and 6.31, respectively. As shown from the figures, all 
characteristic peaks of Poly(L-Lactide) and Poly (D, L-Lactide) are nearly at the same 
wavelenght in their spectra and matched with the literature.[58,59] Characteristic 
absorption bands at 1760 cm-1 and at about 2900 cm-1 are attributed to stretching 
vibrations of the CO and C-H group of PLA, respectively. The peaks at 1450 cm-1 and 
1370 cm-1 come from –CH3 bending and the 2930 cm-1 peak in the figures indicate - 
CH3 stretch. 
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The spectrum of Poly-L-Lactide composites with untreated HA loading of 10 %, 
and 20 wt % samples were given in Figures 6.32 and 6.33 respectively. An absorption 
band at 3570 cm-1 as well as a triplet of absorption bands at 572-632 cm-1 come from the 
OH groups from HA, while characteristic absorption bands with maxima at 1050 and 
1090cm-1 arise from the phosphate groups from HA. The peaks at 1760 cm-1 and 2900 
cm-1 come from the CO and C-H group of PLA, respectively. As shown in the figures 
the peak intensity at 572-632 cm-1 was increased with the increasing hydroxyapatite 
content in the composites.  
The FTIR spectrum of poly(L-Lactide) composite containing 20 wt % HA 
treated with 1 wt % with aminofunctional silane was given in Figure 6.34. The 
characteristic peaks of poly (L-Lactide) and HA were observed in the spectra of the 
composites, however, silanol formation band, which absorbs at 1130-1000 cm-1 was not 
seen. This could be due to the low vibration intensity of silane coupling agent.  
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Figure 6.30. FTIR Spectrum of Poly-L-Lactide. 
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Figure 6.31. FTIR Spectrum of PDLA1 
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Figure 6.32. FTIR Spectrum of Poly(L-Lactide) Composite Containing 10 wt % 
Untreated HA.  
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Figure 6.33. FTIR Spectrum of  Poly(L-Lactide) Composite Containing 20 wt % 
Untreated HA.  
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Figure 6.34. FTIR Spectrum of 20 wt % Treated HA with Aminofunctional Silane – 
Poly(L-Lactide) Composite. 
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6.3. Hydrolytic Degradation of Poly (L-Lactide), Poly(D,L-Lactide) and their 
Composites 
 
For most biodegradable materials, for especially artificial polymers, chemical 
degradation via hydrolysis is the most important mode of degradation. There are several 
other factors such as the type of chemical bond, pH, copolymer composition and water 
uptake affects the rate of this reaction. Therefore, in this study water absorption, percent 
weight loss and pH changes of homopolymers, copolymers and ceramic/ polymer 
composites have been investigated during the hydrolysis reaction with respect to time. 
Since the simulated body fluid (SBF) represents the chemical environment of blood 
plasma, in vitro degradation mechanism of polymers were tested in SBF solutions at the 
physiological pH of 7.4 and at temperature of 37 0C. Specimens subjected to in vitro 
study were the pure polymer films (PLA1, PLA2, PDLA1, PDLA2) and polymer (PLA1 
and PDLA1) composites loaded with untreated HA (10, 20, 30, 50 w/w %). The weight 
loss and water absorption values of these pure polymer films and their composites over 
an 8-week and 16-week period were determined by gravimetric analysis. The samples 
held in an aqueous solution (simulated body fluid) were examined by Scanning Electron 
Microscopy (SEM) at different time intervals to observe the morphological changes 
occurred at the surface as a result of  hydrolytic degradation process. 
 Figure 6.35 illustrates the changes in the pH of the SBF solution over time for 
the polymers under investigation subjected to static tests. In static degradation test the 
SBF solution used for aging was not replaced over the whole testing period. As seen 
from this figure, the pH of the medium containing polymers in all cases did not change 
significantly and stayed stable at around 7.4 up to 150 days. The pH of the SBF 
solutions containing PLA1 and PLA2 increased to 8.2 at the day of 30. 
 Taylor et al [61], studied the in vitro degradation of Poly (L-Lactide) in a buffer 
solution of pH 7.4 at 37 0C. The pH of the aging medium was reduced from 7.4 to 3.0 
after 40 weeks. Up to 40 weeks period, the pH value was nearly the same at the value of 
7.4. Mainil-Varlet and co-workers [62] examined the effect of in vitro degradation in 
the phosphate buffer solution, pH 7.4 at 37 0C for various low molecular weight 
polylactides. The changes of pH, crystallinity and mechanical properties were 
investigated in the static in vitro aging tests. The pH of the medium-containing poly (L-
Lactide) decreased from 7.4 to 6.9 after 40 weeks and reached to a value of 5.4 after 1 
year. For poly (L/D-Lactide) and poly (L/DL-Lactide) polymers, the pH of the 
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phosphate buffers solution decreased over the whole experiment period, approaching 
the value of 3.2 after 5 weeks. 
In this study, since the in vitro static testing in SBF solution for polymeric 
materials were performed within approximately 22 weeks period, no change in pH was 
observed as pointed out in Taylor’s work and results were similar to Mainil-Varlet’s 
study for Poly(L-Lactide). The stability of pH at 7.4 may be because of the good 
buffering effect of SBF solution and the ions present in the medium. Another reason 
may be due to the medium sterilization, therefore, no microbial attack could be the 
cause of any degradation. The change of pH would have been obtained if specimens 
were left in SBF solution over longer periods, because it is assumed that polylactides 
degrades at low rates and that degradation of polyhydroxyacids in the aqueous media 
proceeds via a random, bulk hydrolysis of ester bonds in the polymer chain. The 
carboxylic acids, which are products of the degradation, catalyze the degradation 
process.  
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Figure 6.35 The Change of pH During Degradation Period of Time for PLA1, PLA2, 
PDLA1, PDLA2. 
 
Figure 6.36 displays the weight loss of polymers during 150 days period. Weight loss 
and water absorption values were determined from the Equations 6.3 and 6.4.                                         
 
% WL= [(WI – Wr)/WI ] x 100                                        (6-3) 
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% WA= [ (Ww – WI)/ WI)] x 100                                    (6-4) 
where;  
WI is initial weight, Ww is wet weight and Wr is remaining weight of the 
samples. Weight loss data showed that during 150 days period, the degradation rates of 
PLA1 and PLA2 were much slower than those of PDLA1 and PDLA2.  As shown in the 
figures, at the end of the 150 days, only 12.5 and 9.5 % weights (PLA1 and PLA2) were 
lost, respectively. As expected, degradation of the copolymers was faster than 
degradation of homopolymers and weight loss data of PDLA1 and PDLA2 were nearly 
found to be similar with the values of 17.5% and 17%, respectively. 
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Figure 6.36 Weight Loss Change as a Function of Time for Different Types of 
Biodegradable Polymers (PLA1, PLA2, PDLA1, PDLA2) in Simulated Body Fluid, pH 
7.4 at 37 0C. 
 Li [46] studied the hydrolytic degradation characteristics of aliphatic polyesters 
derived from Lactic and Glycolic Acids in pH 7.4 phosphate buffer at 37 0C. After 40 
weeks, nearly 8 %, 10 % of the weight was lost for PLA and PDLA, respectively. 
 The morphology of a polymeric material (i.e., amorphousness and 
semicrystallinity) plays a critical role in the degradation process. It is known that 
degradation of semicrystalline polyester in aqueous media occurs in two stages. The 
first stage consists of water diffusion into the amorphous regions with hydrolytic 
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breaking of ester bonds. The second stage starts when most of the amorphous regions 
are degraded. PLA1 and PLA2 are intrinsically semicrystalline polymers and PDLA1 and 
PDLA2 are amorphous. The composition of polymer chains, which was the content in 
L-LA and D-LA, effect the degradation rate of PLA polymers.  
 Water absorption data for polymers as a function of degradation time was 
indicated in Figure 6.37. As seen from the figure, the uptake of water by PLA1 was 
slower and lower compared to PLA2, especially in 50 days. After the 90th day, both 
homopolymers showed the similar trend and absorbed the same amount of water ( 11-
12 %) at the day of 150. 
 It can be seen in Figure 6.37 that copolymers PDLA1 and PDLA2 had higher 
water absorptions, the difference between the two polymer being around 5%. At the day 
of 150 PDLA1 and PDLA2 have water absorption values of 16 % and 20 %, 
respectively. It was found that the water absorption of copolymers with lower LA 
content was comparatively higher than those of higher LA content. 
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Figure 6.37 Water Absorption Behaviour of Polylactide (PLA1, PLA2, PDLA1, PDLA2) 
as a Function Degradation Time. 
  
 The effect of HA loading on the degradation behaviour of the polymer 
composites was also investigated. The degradation rates of the PLA1 and PDLA1 
composite containing 10, 20, 30 and 50 % untreated HA were studied. Figure 6.38 (a), 
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(b), (c) shows the changes in the pH of the SBF solution, the % weight loss and water 
absorption of the PLA1 and PDLA1 composite incorporated with 10% untreated HA 
respectively. The in vitro static testing in SBF solution for PLA and PDLA composite 
materials were performed within approximately 13 and 9 weeks period, respectively. As 
seen in Figure 6.38(a), while the pH of the solution containing 10 w/w % HA/PDLA 
composite did not change, pH increase was observed in the case of solutions containing 
10 w/w % HA/PLA composites. The increase in pH was recorded during the first 20 
days, after this period pH remained at around 8.2. This change may be the reason of the 
hydroxyapatite content of polymeric material. HA alone tend to increase the pH’s of the 
SBF solutions due to its composition. It contains PO4-2 and Ca+2 ions; and ion transfers 
may occur both from the material side to the solution and vice versa. In 20 days time; 
pH raised from 7.4 to 8.2, which can be attributed to the equilibration reaction between 
the material and solution. This type of behaviour can not be seen in case of HA/PDLA 
composites even with this polymer having the same amount of HA. The difference may 
be due to the fact that PDLA and PLA polymer structures; their crystallinity, 
homogeniety and making different chemical bonds with HA. Figure 6.38 (b) shows the 
weight loss data for HA/PLA and HA /PDLA composites loaded with 10 w/w % HA. 
For both polymer composites, weight loss curves tend to increase with time; at the day 
of 50 similar values were recorded and approximately 6 % weight losses were obtained. 
The weight loss values are not shown here after 50 days for HA/PDLA composite due 
to the lack of experimental data, the weight loss values stayed stable at 5 % for HA/PLA 
composite material.  
 HA/ PLA and HA/PDLA composites have approximately similar weight loss 
values in Figure 6.38 (b); when compared with the pure polymer materials (Figure 6.36) 
at the day of 50; again nearly the same weight losses were obtained for both polymers 
and polymer /HA composites. Prolonged time periods caused increases in weight loss 
values for PDLA polymers than those of PDLA /HA composites and PLA polymers 
than those of PLA /HA composites. This may be due to the slower degradation of HA in 
SBF when compared with pure polymer materials in the same solutions. Weight loss 
decreases approximately from 9.5% to 5 % when PLA’s were loaded with 10 % HA at 
the end of 90 days. 
 Water absorption data for HA/polymer composites can be seen in Figure 6.38 
(c). Initial rates of water absorption for both HA/PLA and HA/PDLA composites 
showed similarities up to the day of 10. The uptake of water by HA/PDLA was higher 
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than that of HA /PLA composite and reached to a value of 15 % at the day of 60, while 
water absorption value was found to be around 10 % for HA/PLA composite material. 
This value increased up to 13.5 % at the day of 90 for HA/PLA composite, but no data 
is available at this period for HA/PDLA composite for comparison. 
 Water absoption behaviour of pure polymer and polymer composites can be 
compared from the Figures 6.37 and 6.38 (c). It can be said that water uptake increased 
from 10 % to 13 % for PLA when loaded with 10 % HA and water absorption of these 
samples increases. This may be due to the high watering absorption capability of HA 
granules. It is thought that water molecules, which penetrate within the polymeric 
matrix, are responsible for the hydrolytic decomposition of the polyester chains. Most 
probably, HA granules were able to absorb the degradation products, monomers and 
oligomers that further reduced the autocatalytic degradation of the polymer phase. 
Degradation of the composites is much slower especially for the composites with higher 
HA content.  
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Figure 6.38 Change of pH, Weight Loss and Water Absorption of PLA and PDLA 
Composites with 10 wt  % HA with Respect to Degradation Time. 
  
 Shikinami et al [25] studied the hydrolytic degradation of PLA and its 
composites in thin slices of rods. Degradation behaviour of HA particles/PLA 
composites was examined in a solution such as phosphate buffer solution or simulated 
body fluid without the addition of the cells. Generous apatite crystals began to form on 
the surface of composites (40 wt % HA/PLA composites) after 3-7 weeks in SBF at 37 
 108
0C and covered the whole surface with fairly thick layer in 7 weeks. The deposition of 
calcium phosphate crystals after immersion in SBF indicated the bonding capability of 
HA particles to surrounding bone. In other words, the apatite deposition may lead to 
bond a device to bone at start in vivo, and then to reduce a bone hole due to both 
degradation and resorption of PLA by replacing with the surrounding tissue. 
 As it is pointed out in Shikinami et al [25]’s work; even higher HA contents 
(more than 10 w/ w % HA) are desired when preparing polymer composites. Higher  
HA content may lead to better osteointegration of polymeric implants with bone since 
the biodegradability (or resorbability) of polymers are high. 
 Therefore, composites containing 20-50 w/w % HA were also studied. Since dry 
weight of these samples was found higher than the initial weight, the weight loss of 
PLA and PDLA composites loaded with 20-50 w/w % HA could not be determined. 
The values obtained from these type of samples are shown in Appendix 2-A. It can be 
observed that composites containing 20-50 % HA showed different degradation trend at 
the end of 8th weeks. 
 In order to support our findings of degradation studies, the morphological 
changes occurred in PLA composites loaded with 10 and 30 w/w % HA before and after 
8 weeks incubation in SBF and also HA powder were examined using SEM. 
Figure 6.39 shows SEM images of surfaces that contain 10 w/w % untreated 
HA-PLA composites before and after being placed in simulated body fluid. Figure 6.39 
(a) indicated that surface of the Polylactide composite, which contains 10 w/w % 
untreated HA. On scanning electron micrographs, it appeared that the dissolution of the 
HA coating on PLLA and PDLA composite is rather abrupt in nature. A possible 
explanation is that the precipitation of calcium in simulated body fluid is coated into the 
polymer composites. At the end of 8 weeks, Ca2+ and PO43- come from simulated body 
fluid or deposition of HA, disappearance of the HA coating on the polymer surface as 
seen in the scanning micrographs in Figure 6.39 (b). It is also likely that dissolved 
calcium (Ca+2) and phosphate (PO4-3) ions may be utilized in new bone formation and 
also these types of composites have good bone bonding capability. PLA and PDLA 
composites have osteogenic potential. On the other hand, bulk degradation of the 
polymer matrix was observed at the end of 8 weeks as seen in SEM images in Figure 
6.39(c). It was observed that void of surface on polymer has caused the degradation of 
the matrix starting from the inner parts of the material. During this period, morphology 
of the hydroxyapatite was changed as shown in Figure 6.39 (d).  
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(a) PLA Composites content 10 % HA loading before SBF 
 
 
 
(b) PLA Composites Content 10 % HA Loading after 8 Weeks in SBF 
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(c) PLA Composites Content 10 % HA Loading after 8 weeks in SBF 
 
 
(d) Morphology of HA Powder after 8 weeks in SBF 
 
Figure 6.39 SEM Images of Surfaces that Contain 10 wt % Untreated HA-PLA 
Composites Before and After Placed in Simulated Body Fluid. 
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 Verheyen and co-workers [6] studied the degradation behaviour of HA/Poly (L-
Lactide) composites in three different aqueous buffer solutions; Citrate, Gomori’s and 
phosphate buffered saline up to 24 weeks. PLA composites containing 30 w/w % and 50 
w/w % HA showed a significant dissolution of HA coating on PLA in all buffer 
solutions and citrate buffer none. This study supported that the in vitro solubility of 
calcium phosphates is as dependent on the surrounding medium as on the composites. 
And also, increasing the HA content in the composites increased deposition of calcium 
and phosphate ions. 
 Coatings of the composites with calcium layer are much higher especially for 
the composites with higher HA content. In addition, SEM images demonstrated that the 
porosity of polymer matrix increased rapidly in relation to HA content. Figure 6.40 
indicated that SEM photographs of surfaces that contain 30 w/w % untreated HA-PLA 
composites before and after being placed in simulated body fluid during 8 weeks.  
 
 
 
 
(a ) PLA Composites content 30 % HA loading before SBF 
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( b )PLA Composites Content 30 % HA Loading after 8 weeks in SBF 
 
 
 
(c) PLA Composites Content 30 % HA loading after 8 weeks in SBF 
  
Figures 6.40 SEM Images of Surfaces that Contain 30 wt % Untreated HA-PLA 
Composites before and after Being Placed in Simulated Body Fluid. 
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Chapter 7 
 
CONCLUSIONS AND RECOMMENDATIONS 
 
 In the scope of this study, the preparation and characterization of 
Hydroxyapatite-Poly-L-Lactide and Poly-L-Lactide-D-Lactide copolymer composites 
as biomaterial were studied. The effects of polymer types, Hydroxyapatite loading, 
surface modification of Hydroxyapatite and their concentrations on the mechanical, 
microstructural, hydrolytic and thermal degradation properties of the composites were 
investigated. 
 In the preparation of composites, Poly-L-Lactide and Poly-L-Lactide-D-Lactide 
copolymer were used as a matrix and Hydroxyapatite was used as filler. Solvent casting 
technique was used to obtain the polymer composite films. Hydroxyapatite was 
synthesized by the precipitation technique. To improve the dispersion of filler in the 
polymer and the interfacial adhesion between polymers and fillers, the surface of this 
powder has been treated with two different silanes as coupling agents, which were 3-
aminopropyltriethoxysilane (AMPTES) and 3-mercaptopropyl-trimethoxysilane 
(MPTMS).  
 Mechanical test studies indicated that Poly-L-Lactides (PLA1 and PLA2) are 
semicrystalline polymers and their Young’s Modulus were found to be higher than 
poly-D-Lactide-L-Lactide copolymers which have amorphous structure. The effect of 
particle size of HA on the Young Modulus values of the composites was also 
determined in this study. It was found that, Young Modulus value of composite with 10-
wt % HA loading increased from 644.24 MPa to 877.72 MPa as the particle size of HA 
was reduced. The Young Modulus increased with HA loading increase except for the 50 
wt % HA loaded composite. This might be due to the increase agglomeration size of 
HA. 
 Surface treatment of HA with silane coupling agent improved the dispersion of 
HA in the polymer matrix as well as the mechanical properties of the composites. 
According to the tensile test results, the maximum improvement in the mechanical 
properties of the composites was obtained for PLA composites containing 1 wt % 
AMPTES treated HA and 0.5 wt % MPTMS treated HA for PDLA composites. 
Young’s modulus, yield stress values of the PLA composites containing 10 wt % treated 
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HA with 1 wt % AMPTES were found as 982,8 MPa, and 42,1 MPa, higher than those 
of 10 wt % untreated HA loaded composites. 
 The particle size and surface treatment of HA with silane coupling agents 
affected the morphology of the PLA and PDLA composites. The surface treated and 
small particle size of HA was dispersed more homogeneously in polymer matrix. This 
may be due to the decrease in the agglomeration size with surface modification of HA 
by the strenght of interactions between particles. 
 In the FTIR studies, the characteristic peaks of Polylactide and HA was 
observed in the spectra of the composites. However, silane-coupling agents did not 
significantly affect the peaks corresponding to both hydroxyapatite and Polylactide 
composite films. This could be due to the low vibration intensity of silane coupling 
agent. 
Thermal analysis studies indicated that the addition of HA into the polymer 
matrix decreased the thermal degradation temperature and degradation rates. The 
information obtained from TGA studies about the hydroxyapatite content of the samples 
did nearly match with actual amount of HA present in the composites. This also showed 
that HA was dispersed homogeneously in the polymer matrix. 
 The results of hydrolytic degradation properties of the pure polymers and their 
composites showed that the hydrolytic degradation depend on polymer type, the HA 
loading and ageing conditions. The pH of the medium containing polymer or 
composites in all cases did not change significantly end stayed. Weight loss data of pure 
polymers showed that the degradation rates of PLA1 and PLA2 were much slower than 
those of PDLA1 and PDLA2. At the end of 150 days, only 12.5% and 9.5 % of weight 
loss were obtained for PLA1 and PLA2, respectively. Weight loss data of PDLA1 and 
PDLA2 were found to be nearly the same being 17.5 wt % and 17 wt %, respectively. 
On the other hand, PLA and PDLA composites loaded with 10 wt % HA degraded 
slowly while water absorption values increased. Weight loss decreased approximately 
from 12 wt % to 5 wt % and water absorption increased from 10 wt % to 13 wt % for 
PLA with loaded 10 % HA. At the end of 8 weeks, weight loss of PLA and PDLA 
composites loaded with 20-50 wt % HA were not determined, because dry weight of 
samples increased. In order to support our findings of degradation studies, the 
morphological changes occurred on PLA composites loaded with 10-50 wt % HA 
before and after incubation in SBF was examined using SEM. On scanning electron 
micrographs it appeared that the dissolution of the HA coating on PLLA and PDLA 
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composite is rather abrupt in nature. A possible explanation of this is that the 
precipitation of calcium in simulated body fluid is coated into the polymer composites 
and also the dissolution of HA in the polymer matrix. This showed the new bone 
formation and also composites have good bone bonding capacity. It was also found that 
the coating of polylactide composites with calcium phosphate layer was increased with 
the increase HA loading and ageing time. 
 In the future studies, the polylactide-HA composites can be prepared by phase 
separation technique in order to see the effects of preparation method on the 
mechanical, microstructural and hydrolytic degradation properties of the composites. 
The effect of solvent and HA type can also be studied. In the hydrolytic degradation 
studies, ageing conditions of the SBF such as pH, temperature can be changed in order 
to see the effects on degradation behaviour. Mechanical properties of the samples aged 
in SBF can also be monitored. 
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APPENDIX  
 Table A.1. Tensile Test Results of Polylactide-Hydroxyapatite Composites  
 
 Young 
Modulus 
N/mm2 
Stress @ Peak 
N/mm2 
 
Strain @ Peak 
% 
Elongation 
@Break 
mm 
PLA1 833.9 27.7267 3.6793 3.4506 
PDLA1 194.9 9.381 2.4553 1.8383 
PLA2 450.2 17.141 4.4926 3.373 
PDLA2 335.5 4.8731 1.7247 2.313 
MN1 877.7 39.272 4.849 3.423 
MN2 1006.9 24.381 2.8993 2.0753 
MN3 1198.7 27.3133 2.8453 2.0093 
MN4 589.3 7.8967 2.444 1.727 
CD1 982.8 42.118 4.7 3.227 
CD2 1062.4 27.1423 3.41 2.607 
CD3 1420.8 18.89.43 2.1553 1.7253 
CD4 880.2 13.11 1.974 1.475 
DM1 501.3 13.212 4.2327 2.7287 
DM2 643.2 15.1467 3.996 2.4986 
DM3 650.3 16.421 6.369 3.89 
DM4 214.9 14.003 2.8273 2.1746 
HJ1 621.9 18.876 3.3820 2.7156 
HJ2 708.9 14.446 3.2718 2.4586 
HJ3 762.3 15.379 4.4080 2.9886 
HJ4 638.2 14.439 3.3006 2.5196 
AB1 417.2 18.911 3.7753 2.6590 
AB2 463.9 12.577 4.3880 2.8943 
AB3 762.7 18.600 4.1690 2.5830 
AB4 508.7 12.971 2.7080 1.8916 
EF1 632.9 23.4880 4.9770 3.0355 
EF2 843.055 24.2485 3.6150 2.3190 
EF3 1082.20 19.1885 2.6320 1.9575 
Ef4 725.340 15.8380 4.3067 2.7480 
BC1 472.96 12.865 2.9436 2.8086 
BC2 525.51 12.213 2.9075 2.0885 
BC3 561.896 10.991 3.6346 2.4126 
BC4 321.98 9.309 1.8535 1.3550 
KL1 528.736 16.934 5.964 4.216 
KL2 607.26 15.439 5.034 3.7593 
KL3 692.55 14.89 5.0527 3.651 
KL4 571.325 7.5735 2.062 1.548 
C21 565.81 23.1856 4.7705 3.2717 
C12 644.24 28.142 5.1093 3.7416 
P12 676.56 30.991 4.892 3.997 
CD20 929.7 20.970 3.1784 1.9868 
CD22 1084.0 20.754 2.5533 1.7527 
CD21 1263.4 28.771 3.2113 3.0100 
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GH20 1167.0 32.593 4.2555 2.5257 
GH21 972.5033 19.56 2.8426 2.959 
GH22 967.8 21.814 2.8185 1.728 
EF20 462.06 18.62 4.0860 4.509 
EF21 843.055 24.2485 3.6150 2.3190 
EF22 586.32 21.869 4.4413 2.7963 
FG20 528.575 16.1185 4.7 3.053 
FG21 485.22 18.539 5.5067 3.459 
FG22 382.56 10.946 4.4705 2.7215 
KL20 597.203 12.77 3.557 2.26 
KL21 541.52 11.081 3.847 2.594 
KL22 508.185 13.133 3.861 2.749 
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Table A.2. Hydrolytic Degradation Data for Polylactide Composite containing 20 wt %-
30 wt % HA. 
Time, Day  Wi (mg) Wf (mg) 
 MN1   
1  107 106 
2  113 111 
4  124 121 
9  102 100 
16  111 108 
23  137 132 
38  135 129 
52  116 109 
66  120 114 
80  106 101 
94  135 127 
 MN2   
1  104 102 
2  97 95 
4  88 85 
9  88 85 
16  83 79 
23  102 104* 
38  88 94* 
52  109 114* 
66  76 82* 
80  87 94* 
94  92 99* 
 MN3   
1  98 96 
4  108 106 
7  98 94 
14  105 100 
21  107 113* 
35  106 114* 
49  103 112* 
63  95 109* 
 MN4   
1  162 158 
4  154 150 
7  142 138 
14  140 136 
21  146 154* 
35  150 156* 
49  151 159* 
63  160 169* 
 DM1   
1  55 54 
4  45 43 
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7  46 44 
14  46 44 
21  49 47 
35  44 40 
49  45 40 
63  46 39 
 DM2   
1  49 48 
4  57 55 
7  53 49 
14  48 46 
21  46 51* 
35  43 47* 
49  42 45* 
63  40 46* 
 DM3   
1  46 45 
4  43 42 
7  47 45 
14  45 43 
21  45 49* 
35  36 39* 
49  44 49* 
63  47 53* 
 DM4   
1  98 96 
4  76 74 
7  71 69 
14  41 48* 
21  61 69* 
35  45 56* 
49  53 61* 
63  63 72* 
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NOMENCLATURE 
PLA1: Poly L-Lactide from PURAC 
PDLA1: 96/4 L-Lactide, D-Lactide Copolymer from PURAC 
PLA2: Poly L-Lactide from Boehringer Ingelheim 
PDLA2: 67/23 Poly (L-Lactide-co-D,L-Lactide) from Boehringer Ingelheim 
HA1: Commercial Hydroxyapatite powder 
HA2: Reduced particle size of commercial Hydroxyapatite powder 
HA3: Synthesized Hydroxyapatite powder in laboratory 
HAs1:  Treated synthesized Hydroxyapatite powder in laboratory with AMPTES 
HAs2:  Treated synthesized Hydroxyapatite powder in laboratory with MPTMS 
MN1: 10 wt % HA3 /PLA1 Composite 
MN2: 20 wt % HA3 /PLA1 Composite 
MN3: 30 wt % HA3 /PLA1 Composite 
MN4: 40 wt % HA3 /PLA1 Composite 
CD1: 10 wt % HAs1 /PLA1 Composite 
CD2: 20 wt % HAs1 /PLA1 Composite 
CD3: 30 wt % HAs1 /PLA1 Composite 
CD4: 40 wt % HAs1 /PLA1 Composite 
DM1: 10 wt % HA3 /PDLA1 Composite 
DM2: 20 wt % HA3 /PDLA1 Composite 
DM3: 30 wt % HA3 /PDLA1 Composite 
DM4: 40 wt % HA3 /PDLA1 Composite 
HJ1: 10 wt % HAs2 /PDLA1 Composite 
HJ2: 20 wt % HAs2 /PDLA1 Composite 
HJ3: 30 wt % HAs2 /PDLA1 Composite 
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HJ4: 40 wt % HAs2 /PDLA1 Composite 
AB1: 10 wt % HA3 /PLA2 Composite 
AB2: 20 wt % HA3 /PLA2 Composite 
AB3: 30 wt % HA3 /PLA2 Composite 
AB4: 40 wt % HA3 /PLA2 Composite 
EF1: 10 wt % HAs1 /PLA2 Composite 
EF2: 20 wt % HAs1 /PLA2 Composite 
EF3: 30 wt % HAs1/PLA2 Composite 
EF4: 40 wt % HAs1 /PLA2 Composite 
BC1: 10 wt % HA3 /PDLA2 Composite 
BC2: 20 wt % HA3 /PDLA2 Composite 
BC3: 30 wt % HA3 /PDLA2 Composite 
BC4: 40 wt % HA3 /PDLA2 Composite 
KL1: 10 wt % HAs2 /PDLA2 Composite 
KL2: 20 wt % HAs2 /PDLA2 Composite 
KL3: 30 wt % HAs2 /PDLA2 Composite 
KL4: 40 wt % HAs2 /PDLA2 Composite 
C21: 10%wt HA1/PLA1 Composite (PLA1+SOLVENT+HA1) 
C12: 10%wt HA1/PLA1 Composite (HA1+SOLVENT+ PLA1) 
P12: 10%wt HA2/PLA1 Composite (HA1+SOLVENT+ PLA1) 
CD20: 20%wt HAs1 /PLA1 Composite with 0,5 wt % AMPTES/HA3 
CD21: 20%wt HAs1 /PLA1 Composite with 1 wt % AMPTES/HA3 
CD22: 20%wt HAs1 /PLA1 Composite with 2 wt % AMPTES/HA3 
GH20: 20%wt HAs2 /PLA1 Composite with 0,5 wt % MPTMS/HA3 
GH21: 20%wt HAs2 /PLA1 Composite with 1 wt % MPTMS/HA3 
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GH22: 20%wt HAs2 /PLA1 Composite with 2 wt % MPTMS/HA3 
EF20: 20%wt HAs1 /PLA2 Composite with 0,5 wt % AMPTES/HA3 
EF21: 20%wt HAs1 /PLA2 Composite with 1 wt % AMPTES/HA3 
EF22: 20%wt HAs1 /PLA2 Composite with 2 wt % AMPTES/HA3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
